Filtered library · Conviction
LOW conviction · 602 dossiers
Every dossier the model currently rates LOW conviction — 602 names, with thesis, invalidation trigger, archetype and catalyst.
All 602 are dated research with a published kill line — the level named in advance that would prove the call wrong.
All dossiers ARCB ArcBest Corporation fresh LOW ArcBest’s cost-reduction rebound failed its published price condition at the 2026-09-18 weekly close of $128.73. Third-quarter results still test recurring savings and preservation of the second-quarter 90.8% adjusted Asset-Based operating… ATEX Anterix Inc. fresh LOW Anterix’s utility-spectrum conversion thesis failed its published price test when the 2026-09-18 weekly close of $76.99 breached $85.31. A new utility agreement with disclosed payments and a weekly recovery above $85.31 would support a… CNC Centene Corporation fresh LOW Centene's margin-repair case requires sustained earnings guidance and a weekly close above $68.72 by its 2026-10-27 results. September's reaffirmation supports the earnings leg, but a weekly close below $65 or withdrawal or reduction of… DAVE Dave Inc. fresh LOW Dave Inc.'s growth-and-credit-quality recovery case is invalidated by the September 18, 2026 weekly close of $337.82 below its published $358 boundary. JPMorgan's September 15 initiation adds favorable coverage but does not reverse that… DELL Dell Technologies Inc. fresh LOW Dell Technologies’ AI-server thesis requires roughly $19 billion of next-quarter revenue and infrastructure operating margin of at least 15.0%. The next quarterly results settle that case; September 21, 2026 index inclusion does not… HNGE Hinge Health, Inc. fresh LOW Digital-MSK profitability re-rate broke out in May and was pushed into open price discovery by the 2026-06-09 mid-quarter raise (Q2 to $200–202M, +45%; FY26 to $818–824M). But nine sell-side target hikes in two weeks plus accelerating… HUM Humana Inc. fresh LOW Humana's Medicare Advantage margin-recovery story faces a renewed price test: an adjusted daily close above $409.80 before a daily close below $383. The September 1, 2026 earnings reaffirmation supports stability, while October Star… JBHT J.B. Hunt Transport Services, Inc. fresh LOW J.B. Hunt’s freight-recovery thesis was invalidated by the 2026-09-18 weekly close below $265. The estimated 2026-10-15 report tests whether intermodal pricing and profit growth can support a separate recovery case after September’s cost… LSTR Landstar System, Inc. fresh LOW Landstar System's truckload repricing must produce further earnings improvement. The 2026-10-27 results settle the case if truck revenue per load grows year over year and earnings per share exceed the second quarter's $1.44 before a weekly… MRVL Marvell Technology, Inc. fresh LOW Custom-silicon ASIC royalty story intact, but the AI-semi theme is mid-correction — chips posted their worst month vs software on record (7/17) with money rotating into energy. Buying a falling sector with no confirmed higher low is the… SEZL Sezzle Inc. fresh LOW Sezzle's profitable-growth recovery thesis requires a daily close above $129.87 before a weekly close below $114 invalidates it. The 2026-09-18 adjusted close of $116.55 lost the August shelf again, reversing the intermediate repair… SNX TD SYNNEX Corporation fresh LOW TD SYNNEX's Hyve expansion supports an AI hardware earnings story, tested by revenue above $19.0 billion and adjusted diluted EPS above $4.75 on 2026-09-24. A weekly close below $255 invalidates the September price structure; stronger… STX Seagate Technology Holdings PLC fresh LOW Maturing AI-storage supercycle with sell-side still chasing: Wells Fargo upgrade to Overweight $1,100 (7/10) and Citi Street-high $1,240 (7/13). But the DRAM ETF is down ~30% and Seagate's Q4 FY26 print ~2026-07-22 is a binary about two… UMC United Microelectronic Corp. fresh LOW Silicon-photonics pivot re-rated the ADR ~3x, but the July blowoff to $28.96 round-tripped -26% to $21.25 in days while sell-side finally upgraded (Macquarie Outperform 2026-07-14) — late-stage distribution behaviour. The 2026-07-29 Q2… WDC Western Digital Corporation fresh LOW The 29% bounce off the 2026-07-28 low stalled: WDC closed $527.22 on 2026-08-03, −3.23% on a day its sector rose 0.58%, back under a rising 50-day at $562.65. Consensus (~$3.69B / $3.31–$3.35) still sits above the company's own $3.65B… XPO XPO, Inc. fresh LOW XPO, Inc.'s shipment-and-margin thesis failed its price test when the 2026-09-18 weekly close of $174.25 breached $185. The 2026-10-29 results still test shipment growth and management's guidance for an adjusted less-than-truckload… AESI Atlas Energy Solutions Inc. fresh LOW Frac-sand legacy pivoting to behind-the-meter gas power for AI data centers, but the story is DORMANT and the structure broken: shares fell from $16.73 (6/29) to an $11.96 close (7/24, -8.5%), losing the ~$15 base and $13 shelf on… AMLX Amylyx Pharmaceuticals, Inc. fresh LOW Amylyx Pharmaceuticals’ avexitide story now depends on a year-end 2026 NDA submission and recovery above the $35.50 offering price. An announced submission and a weekly close above that level complete the case; a weekly close below $30… AMR Alpha Metallurgical Resources, Inc. LOW Alpha Metallurgical Resources’ coal-supply-shock thesis requires stronger third-quarter realized pricing before August support breaks. Realization above the second quarter’s $118.71 per short ton would confirm transmission; a weekly close… ANF Abercrombie & Fitch Co. fresh LOW Abercrombie & Fitch’s margin re-rating lacks price confirmation after the 2026-09-18 close of $135.76. Continuation requires a weekly close above $152.08 before Q3 results, estimated for 2026-11-24, without first closing below $130. ASMB Assembly Biosciences, Inc. LOW Assembly Biosciences confirmed its Gilead profit-share option on 2026-09-08, but its momentum thesis failed at the September 11 close below $30. The remaining development case requires GS-1179 to enter Phase 2 by year-end 2026; a disclosed… BB BlackBerry Limited fresh LOW Q1 FY27 gave the pivot real numbers (QNX $72.3M vs the $60-64M guide, FY27 raised to $594-621M), but the parabola broke: after a $13.59 high the stock fell ~37% to ~$8.54 on a meme unwind plus insider selling. Narrative maturing, price… BLSH Bullish LOW Bullish's regulatory repricing thesis requires successful CLARITY Act cloture followed by a weekly close above $37.10 before a weekly close below $31. The September 15, 2026 milestone is motion ripening, while the September 9 close of… BMEA Biomea Fusion, Inc. fresh LOW Biomea Fusion’s icovamenib thesis depends on lasting glucose control after limited treatment. COVALENT-211 must meet its placebo-controlled primary endpoint in the company-guided Q1 2027 window before a weekly close below $1.60 invalidates… BMNR BitMine Immersion Technologies, Inc. LOW Premium-to-NAV funding engine is closed; the 2026-08-10 release shows capital flipping from coin to float — 7,391 ETH bought for $14.3M (smallest week of 2026) against 3.0M shares retired, with cash down to $104M from $173M. The narrative… BTCS BTCS Inc. LOW BTCS Inc.’s Ethereum recovery thesis requires stronger DeFi earnings without renewed borrowing. The next Q3 disclosure must show gross profit above Q2 2026’s $1.5 million and debt no higher than June’s $50.4 million before a weekly close… BXC BlueLinx Holdings Inc. fresh LOW BlueLinx's specialty-margin re-rating depends on Trex execution and price repair. Completed initial stocking followed by a weekly close above $84 would resolve the recovery case; a weekly close below $72 would invalidate it. CDE Coeur Mining, Inc. fresh LOW Coeur Mining’s cash-backed repair thesis requires price recovery and confirmation that reduced production guidance holds. A weekly close above the September $21.24 reference and reaffirmed guidance at the next quarterly report would… CLYM Climb Bio, Inc. fresh LOW Climb Bio's re-rating depends on Q4 2026 budoprutug patient data establishing clinical benefit. Recovery of the $17.84 adjusted annual high would confirm the price leg; a weekly close below $13.30 or a delay beyond the guided clinical… CRCL Circle Internet Group, Inc. LOW Circle Internet Group's Arc-led infrastructure breakout failed when its 2026-09-09 close of $92.99 breached the published $95 boundary. The scheduled 2026-09-16 public launch still tests delivery, while any recovery case requires renewed… DHT DHT HOLDINGS, INC. LOW DHT Holdings’ tanker-rate story depends on strong charter bookings sustaining its September 11 high through the next results. Confirmation requires reported earnings to meet the disclosed booking benchmark and the release week to close… DSX Diana Shipping, Inc. LOW Diana Shipping's higher charter rates underpin a near-term breakout thesis, settled by a weekly close above $3.01 before a weekly close below $2.97. Those levels are the adjusted annual high and latest daily close in the September 11, 2026… EMBC Embecta Corp. LOW Embecta Corp.’s earnings-and-debt recovery story needs price confirmation after the September retreat. A weekly close above the September 2 reference close of $5.69 would satisfy the recovery case; a weekly close below $4.60 would… ESTC Elastic N.V. LOW AI-retrieval-layer narrative accelerating: Q4 FY26 total RPO $1.98B grew 28% YoY against revenue +16%, and the 2026-07-30 OpenAI partnership re-rated the name 56.8% in three months. The 2026-08-27 Q1 FY27 print is the binary — company… FDMT 4D Molecular Therapeutics, Inc. LOW 4D Molecular Therapeutics’ durability thesis needs timely Q3 clinical execution to restore the advance; a weekly close above the August 21 reference of $15.83 would complete the recovery case before a weekly close below $12.50 invalidates… FIVN Five9, Inc. fresh LOW Legacy-CCaaS AI pivot staged a sharp V-recovery: +29% off the $19.70 June swing low to $25.42, reclaiming the broken $22 shelf on a 2026-06-23 next-gen Voice AI Agents launch and an AI-first leadership overhaul. Now pressing the $26.26… FLXS Flexsteel Industries, Inc. fresh LOW Flexsteel Industries’ operating-turnaround thesis requires a weekly close above $84.20 before a weekly close below $79.69. These are the high and reference close in the September 18, 2026 market snapshot; weaker quarterly margins limit… FRO Frontline Plc LOW Frontline's tanker-rate boom supports an earnings-persistence thesis, conditional on retaining the September high. The 2026-11-30 results test whether third-quarter vessel earnings sustain the second-quarter benchmark before a weekly close… FWDI Forward Industries, Inc. LOW Forward Industries' Solana treasury re-rating requires growing tokens per share and a verified recovery to net asset value. Updated disclosure must show fully diluted mNAV at or above 1.0x and SOL per share of at least 0.0754 before a… GPRK Geopark Limited LOW GeoPark's Venezuela redevelopment deal creates a revaluation case. A weekly close above the $11.97 reference high would confirm the price thesis before a weekly close below the September 11 reference close of $11.48 invalidates it. HAFN Hafnia Limited LOW Hafnia Limited’s tanker-earnings surge supports a continuation case at its 2026-09-11 high. The 2026-11-18 results test earnings durability, while a weekly close below $9.38 invalidates the price thesis. HBB Hamilton Beach Brands Holding Company fresh LOW Hamilton Beach Brands' tariff-refund re-rating needs durable underlying margins and renewed price strength. A weekly close above the September 11 reference high of $33.86 before a weekly close below $28.00 completes the price case;… HIVE HIVE Digital Technologies Ltd. fresh LOW BTC-miner→AI-compute re-rating has its first blue-chip proof — BUZZ HPC's $220M Bell/Cohere sovereign-AI GPU deal (~$70M ARR) on top of $35M contracted ARR — but the stock stalled ~$3.79 below its early-June highs as BTC bled ~45-50% off… IMMX Immix Biopharma, Inc. LOW Immix Biopharma’s NXC-201 story hinges on late-September data extending the reported 95% response rate across more patients. Confirmation requires that update by 2026-09-30 before a weekly close below $11.00; company language does not… IMRN Immuron Limited LOW Immuron’s consumer-health expansion needs a dated US PROIBS launch and disclosed commercial terms to validate its September repricing. The 2026-09-04 agreement supplies neither; a weekly close below $1.65 or an annual report without those… INBX Inhibrx Biosciences, Inc. LOW Inhibrx Biosciences’ advance prices HexAgon clinical success and a Phase 3 start within the guided quarter. The 2026-09-08 results and September start confirmation test that case; a weekly close below $104 or reported primary-endpoint… INSP Inspire Medical Systems, Inc. LOW Inspire Medical Systems' rally prices a recovery from reimbursement disruption. A weekly close at or above Stifel's September 11, 2026 target of $80 would confirm the price case, while a weekly close below the September 11 reference close… JILL J.Jill, Inc. fresh LOW J.Jill's post-earnings continuation thesis failed when the 2026-09-18 weekly close of $23.94 breached its published $24.08 threshold. Third-quarter results must separately confirm management's projected sales acceleration. KELYA Kelly Services, Inc. fresh LOW Kelly Services' staffing-recovery thesis depends on Q3 2026 meeting revenue and margin guidance before a weekly close below $15. The 2026-09-18 close of $16.14 has lost the former $16.31 shelf, weakening the price evidence ahead of that… KFRC Kforce Inc. fresh LOW Cyclical staffing recovery is fully printed — Q1 returned to YoY growth, Q2 guided +~4% — but price ran ~24% in three weeks to a fresh all-time high near $58.6, ~38% above the $42.33 consensus PT, into the confirmed 2026-07-27 Q2 print. A… KURA Kura Oncology, Inc. LOW The binary already fired: KOMZIFTI's 2025-11-13 approval and ~40% R/R NPM1 share are priced, and the $24–28 targets need a frontline Phase 3 that doesn't read until 2028. The tape is drifting — $10.39, lower third of the H1 range. A… MAN ManpowerGroup fresh LOW Cyclical staffing inflection confirmed by the 2026-08-07 10-Q, but sell-side marks stopped moving 2026-07-20 and the next company binary is ~2026-10-15. MARA MARA Holdings, Inc. fresh LOW AI/HPC power-buildout re-rate is the leg being bought — the 2026-07-09 HIF deal adds up to 2 GW in Texas, lifting potential capacity toward ~4.8 GW — but the golden-cross base fully round-tripped to ~$11.4 as analysts cut across the board… MPC Marathon Petroleum Corporation LOW Record refining cracks are already in the tape: Q2 R&M margin $36.33/bbl vs $17.58 YoY and a 29% EPS beat on 2026-08-04, yet the stock closed 2026-08-07 at $298.20 — RSI 37.3, 6.7% under the $319.76 high — while six desks raised targets… MSTR Strategy Inc LOW Strategy Inc.'s bitcoin accumulation thesis needs successive purchase disclosures and STRC recovering its $100 stated amount. Those milestones must arrive before a weekly close below $123 invalidates the price structure. MXL MaxLinear, Inc. fresh LOW The AI-optical revenue leg still compounds — Q3 guided to $210–220M against Q2's $168.8M — while the price leg makes new lows: the 2026-09-04 close of $62.74 is 51.0% below the $128.03 high with RSI(14) at 25.1, after roughly $50M of… MYGN Myriad Genetics, Inc. fresh LOW Legacy hereditary-cancer testing house executing a diagnostics pivot; shares +40% off the June $3.99 base as Prolaris+AI launched (May 26) and Precise MRD colorectal/renal was pulled forward to Q3. Structure has repaired but now… NSP Insperity, Inc fresh LOW Insperity's margin-repair re-rating requires a weekly close above $53.40 before a weekly close below $48. Third-quarter employee volumes must meet the 305,500 guidance floor and the full-year adjusted EBITDA floor must remain at least $185… NVAX Novavax, Inc. LOW Novavax's Matrix-M royalty re-rating needs company-confirmed Sanofi trial timing at the 2026-09-09–2026-09-10 conferences. The near-term case fails if both pass without that timing or a weekly close falls below $9.00. OABI OmniAb, Inc. LOW OmniAb’s milestone re-rating depends on repeat partner payments lifting full-year revenue guidance above $36 million at the next results. A weekly close below $3.82 ends the price thesis; the October 6 Investor and Analyst Day provides an… ODD ODDITY Tech Ltd. fresh LOW Broken compounder with exactly one dated event: the 2026-09-09 pre-market Q2 print. Price ran $13.22 (2026-08-21) to $14.35 (2026-08-28) on no company disclosure since 2026-07-22, leaving it ~30% above the $11.07 consensus target of 10… PANL Pangaea Logistics Solutions Ltd. LOW Dry-bulk recovery is in the P&L but not the tape: Q1 2026 (2026-05-11) adjusted EBITDA +70% YoY to $25.2M on $15,252/day TCE, yet the stock closed $7.42 on 2026-08-07, 20.1% under the $9.29 52-week high. The 2026-08-10 Q2 print is the… PAYS Paysign, Inc. LOW Paysign’s patient-affordability expansion can sustain its August re-rating if Q3 meets revenue and program guidance and retains the full-year outlook. A weekly close below $11.50 invalidates the market thesis before that confirmation. PRPO Precipio, Inc. LOW Precipio’s diagnostics growth and renewed operating cash generation support a conditional recovery toward its recorded $32.37 high. A weekly close above that level confirms the price case; a weekly close below the 2026-09-11 reference… PTEN Patterson-UTI Energy, Inc. LOW Rig-reactivation cyclical is basing, not broken: June averaged 95 US rigs (vs ~90 Q2 guide), the July EIA STEO lifted 2026 Henry Hub to $3.67, gas rigs turned up 122→126, and Piper upgraded to Overweight 07-14. Price bottomed $8.57 (07-01)… QRVO Qorvo, Inc. fresh LOW Qorvo trades as a fixed-ratio merger spread: 0.960 SWKS plus $32.50 cash. Skyworks' $74.02 close on 2026-09-04 implies $103.56 against Qorvo's $102.84 — about 0.70% gross, the thinnest of this coverage, after the acquirer rallied 12.5% in… RHI Robert Half Inc. fresh LOW White-collar staffing in secular decline: Q2 EPS collapsed to $0.26 (2026-07-23) as AI automation and a frozen hiring market gut permanent-placement demand. The >5% dividend yield reads as a value-trap signal rather than a floor. No… RPD Rapid7, Inc. fresh LOW Rapid7's cost-cutting recovery needs Q3 2026 results to meet revenue and recurring-revenue guidance while preserving the 20% Q4 adjusted operating-margin goal. A weekly close below $10.60 or withdrawal of that goal invalidates the case. RUM Rumble Inc. fresh LOW The sell-the-news break is now confirmed: RUM lost the $6.46–$6.66 100/200-day shelf and closed $5.76 on 2026-07-17, -19% from the post-rebrand tape and within 25% of the $4.62 52-week low. Every moving average is overhead. The 2026-08-10… SDGR Schrodinger, Inc. fresh LOW Agentic-AI software leg: the 2026-08-05 Bristol Myers Squibb agreement to deploy Bunsen at scale landed with a double beat (Q2 revenue $58.889M vs $47.228M consensus) and a raised drug-discovery guide of $65–75M. ACV grew 27% while… SENS Senseonics Holdings, Inc. LOW Only year-long implantable CGM, clinically de-risked at ADA 2026 with revenue +71.9% YoY TTM — and the tape has spent six weeks grinding back toward the $4.79 post-catalyst low ($5.11 on Jul 17). Accelerating fundamentals against a broken… SG Sweetgreen, Inc. fresh LOW Sweetgreen’s recovery thesis links sales stabilization to KeyBanc’s 2026-09-08 target of $9. The next quarterly results test the operating case; a daily close at or above $9 completes the price case, while a weekly close below $6.00… SID Companhia Siderurgica Nacional S.A. (CSN) fresh LOW New-CEO deleveraging story: Fabio Schvartsman replaced 24-year CEO Benjamin Steinbruch on 2026-09-03 and the ADR ran from $1.13 (09-01) to $1.22 (09-04) with RSI at 79.2, while R$42.1bn net debt and 3.49x leverage are untouched until a… SMCI Super Micro Computer, Inc. fresh LOW Dilution leg has broken the story: the $7B raise cleared at $27.50 on June 11 and spot is $24.18, with a live $2B ATM as forward supply. DDR contract prices +32% QoQ crush a business guiding 8.2–8.4% gross margin. Falling knife under all… SMTC Semtech Corporation fresh LOW The mix-purification leg has lost its price leg: the August bounce round-tripped from a $140.35 close on 2026-08-14 to $124.09 on 2026-08-21, under the 2026-07-17 flush close. The binary moved forward — Q2 FY27 prints 2026-08-25 after the… TEM Tempus AI, Inc. LOW Tempus AI's proposed Personalis acquisition supports a cancer-vaccine sequencing recovery thesis. A daily close above the August 21 reference close of $72.69 would confirm the price case before a weekly close below $58 invalidates it;… TITN Titan Machinery Inc. LOW Titan Machinery’s farm-equipment recovery re-rating requires falling total inventory and preserved earnings guidance at its next quarterly report. A weekly close below $23 would invalidate the market thesis before confirmation. TNET Trinet Group, Inc. fresh LOW TriNet Group’s margin recovery depends on Q3 insurance costs holding below 89.5% without July’s nonrecurring benefit. The case resolves positively if FY2026 earnings and revenue guidance also hold before a weekly close below $65… TNK Teekay Tankers Ltd. LOW Teekay Tankers’ record freight earnings underpin a continuation thesis requiring third-quarter rates to meet July booking benchmarks before a weekly close below $100.83. The next earnings report tests that persistence; its publication date… TRMD TORM plc LOW TORM plc’s freight-earnings story supports a conditional move to Evercore ISI’s $38 target, reported on 2026-08-27. The case succeeds at a daily close at or above $38 before a daily close below the 2026-09-11 reference close of $35.08… UPXI Upexi, Inc. LOW Upexi’s Solana-discount recovery requires positive audited net assets and a Nasdaq bid-price cure. The September 28 annual-report checkpoint is provisional, while a weekly close below $1.00 invalidates the recovery structure. W Wayfair Inc. fresh LOW Margin-inflection turnaround has stalled: after the June Evercore-driven pop, W has faded ~10% back to the ~$84–85 recovery base ahead of the binary Aug 4 Q2 print. Wedbush's Jul 16 Neutral/$104 initiation and a ~$100-capped consensus mark… WEAV Weave Communications, Inc. LOW Beaten-down vertical-SaaS front-office platform for healthcare SMBs, down ~36% YTD and basing off the $4.24 low, repositioning around AI-receptionist monetization (TrueLark, 2025). Still a ~17% grower with GAAP losses, so the re-rate is… WGS GeneDx Holdings Corp. fresh LOW Busted-growth genomics name; the recovery off the −49% May guide-cut crash has stalled in the low-$60s, below the $74.83 200-day. The confirmed Aug 3 Q2 print (blended ARR vs the ~$3,300 baseline) is the binary — the same day as the… WPP WPP PLC fresh LOW WPP’s re-rating rests on revenue stabilisation after the September index-promotion case expired. The next quarterly update must improve on the 2.8% like-for-like decline and retain 12–13% margin guidance before a weekly close below $24… WT WisdomTree, Inc. fresh LOW WisdomTree’s record August assets and September 17 MoonPay agreement support a fee-growth rerating thesis. A weekly close at or above the $25.04 annual high observed September 18, 2026 confirms the price case; a weekly close below that… XNCR Xencor, Inc. LOW Xencor’s post-settlement re-rating depends on October XmAb819 data supporting a pivotal-dose choice and the planned 2027 study. A weekly close below $23.34 or withdrawal of that timetable invalidates the continuation case. XXI Twenty One Capital, Inc. LOW The one re-rate catalyst just died: Tether's Strike–Elektron three-way merger was scrapped on 2026-07-21 and CEO Jack Mallers quit, dropping XXI to a fresh all-time low near $4.46. A leveraged-Bitcoin-treasury proxy stuck below 1.0x float… ARM Arm Holdings plc fresh LOW Data-center royalty doubled YoY for a second quarter, but Q2 FY27 royalty growth is guided to ~13% against 22% delivered. No Arm-specific disclosure has landed since 2026-07-29, so the bid is set by third parties — BofA's 2026-08-13… BFLY Butterfly Network, Inc. fresh LOW Butterfly Embedded chip-licensing story got marquee validation — Midjourney's up-to-$74M/5yr full-body scanner on 40 Ultrasound-on-Chip modules (2026-06-18) plus 2nd partner Aleph Neuro (2026-06-25). Fundamentals still accelerating, but… COHR Coherent Corp. fresh LOW Coherent’s AI-optics recovery requires a named PhotonLink customer and production timing at the 2026-09-21 launch. Those disclosures and a subsequent weekly close above $281.86 complete the case before a weekly close below $264 invalidates… GLW Corning Incorporated fresh LOW Corning’s fiber-demand thesis requires Q3 2026 core sales of at least $4.9 billion and optical growth of at least 20% before a weekly close below $143. The sales threshold is management’s July guidance floor; the growth threshold is the… GLXY Galaxy Digital Inc. fresh LOW Galaxy Digital's data-center revaluation depends on Q3 Helios leasing revenue meeting its approximately $80 million forecast, with project-level adjusted EBITDA margins above 90%, before a weekly close below $24. The 2026-09-18 close of… HUT Hut 8 Corp. fresh LOW Bitcoin-miner-to-AI-datacenter-landlord re-rate is now financed fact ($4.25B IG notes 6/4, ~$16.8B contracted backlog), but the momentum leg rolled from ~$127 to ~$105 as peers WULF/IREN captured the marquee Anthropic tenant deals (7/6)… INTC Intel Corporation fresh LOW Funded legacy-pivot leg is holding the $101.65 pre-announcement shelf by under a dollar after the 2026-08-14 close of $102.50; CEO Tan's Form 4 (105,263 sh at $95.00) is the only fresh company datapoint in a week of 13F-derived coverage.… KYMR Kymera Therapeutics, Inc. fresh LOW Oral STAT6 degrader (KT-621) re-rated on early BROADEN2 enrollment (6/25) and the $10.9B AbbVie–Apogee read-through, but the analyst upgrade cycle topped with RBC's 7/13 downgrade to neutral and the binary topline is 2H-2026 — a maturing,… LRCX Lam Research Corporation fresh LOW The WFE/AI-memory capex trade that ran Lam +119% YTD into June has rolled into a group-wide correction — the worst month for chip stocks since 2008, memory momentum broken (Micron/SanDisk). The ~2026-07-29 FQ4 print is now the binary: it… MP MP Materials Corp. fresh LOW MP Materials' domestic-magnet recovery failed its $50 weekly-close test on 2026-09-18; Q4 2026 General Motors shipments remain the unresolved operating test. NVDA NVIDIA Corporation fresh LOW July de-rating unresolved and now compounded by capex scrutiny — Alphabet's first cash-flow-negative quarter since 2004 and Intel's punished $20B capex plan raise the question of whether hyperscaler spend slows. Jensen's open-weight-AI… ONTO Onto Innovation Inc. fresh LOW June breakout fully round-tripped: ATH $386.46 (6/30) to $279.85 (7/17), now below the 50-DMA at $294.49. The tell is non-participation — TSMC raised capex to $60-64B and ASML guided up twice on 7/15-16, and ONTO closed the week at its… PURR Hyperliquid Strategies Inc fresh LOW The gamma-squeeze/index leg is over: PURR is -42% from its 6/1 high of $11.62 to $6.68 (7/17), through the $7.70 shelf, and now trades at roughly 0.78x the value of its 17.6M HYPE stack — a treasury premium that has flipped to a discount,… QCOM QUALCOMM Incorporated fresh LOW The data-center re-rating already failed: QCOM spiked to a 52-week high of $259.92 on the ~2026-06-24 Investor Day $15B-by-2029 guide, then gave back ~34% in 17 sessions to $171.78 as Hold downgrades and Apple modem-attrition math… SHLS Shoals Technologies Group, Inc. fresh LOW Solar/BESS EBOS name re-rated as a 2nd-order AI-datacenter-power play on a record $758M Q1 backlog and the multi-GW ON.energy deal; price reclaimed the $10 pivot but consensus PT sits at spot (~$10.63 vs $10.02), so the confirmed… SYRE Spyre Therapeutics, Inc. fresh LOW Two of three lead binaries (SPY001, SPY002 anti-TL1A) printed potential best-in-class; the stock absorbed a ~$399.7M director-fund block sale and sits back near its ~$102 ATH (~$95). Next legs — SPY003 IL-23 Part A (guided mid-2026,… TNGX Tango Therapeutics, Inc. fresh LOW Post-data digestion, not acceleration: the 92% ORR combo print is fully paid for and the tape has faded from $32.90 to ~$27.7, below the $30.00 June secondary. Sell-side keeps marking up (JPM Overweight $46 on 7/15, Mizuho $40 on 7/17)… TSM Taiwan Semiconductor Manufacturing Company Ltd. fresh LOW Q2 (7/16) beat every line and lifted FY26 growth guide above 40%, but the capex raise to $60–64B and a 2026-07-26 Samsung–Broadcom $200B foundry pact reopened the monopoly question. Theme cooled to maturing; price recovered to ~$415, still… VRT Vertiv Holdings Co fresh LOW Vertiv's grid-power expansion supports a recovery case requiring Q3 2026 revenue to meet July guidance and a weekly close above $285.78. A weekly close below $240 or Q3 revenue below $3,650 million invalidates it; the September 18 close of… WEST Westrock Coffee Company fresh LOW Westrock Coffee’s Conway expansion supports a cash-generation revaluation, but repeat cash flow remains unproven. Confirmation requires positive third-quarter 2026 free cash flow, maintained annual guidance and a weekly close above the… WTI W&T Offshore, Inc. fresh LOW W&T Offshore’s oil-to-cash recovery case has weakened as the 2026-09-18 adjusted close of $3.84 slipped below the dated $4.01 recovery hurdle. The thesis resolves with a daily close at or above the market’s $4.89 trailing-year high before… AA Alcoa Corporation LOW Alcoa Corporation’s tariff-supported earnings story needs a recovery above the September 3, 2026 close of $51.05. Management’s September 10 argument that Canadian duty relief could help remains unconfirmed by price; a weekly close below… AAOI Applied Optoelectronics, Inc. LOW Applied Optoelectronics’ optical-transceiver expansion needs Q3 revenue of at least $255M and a weekly recovery above $110.21 to validate the case. A weekly close below $100 invalidates the recovery thesis. AAON AAON, Inc. fresh LOW Beat-and-raise on 2026-08-10 (Q2 sales $627.0M, +101.2%; FY guide up to $2.235–2.307B) landed with gross margin 24.3% vs 26.6% and the FY margin guide cut to 25–26%. Targets were cut the next day and the entire 2026-05-07 re-rating gap has… AAPL Apple Inc. LOW July's rotation-crown has slipped — Polymarket now gives Apple 20% odds of ending 2026 as the largest company (7/24) and semis are breaking out again (NVDA 7/23). The live narrative is the 'anti-CapEx AI trade' as Alphabet turns… ABEO Abeona Therapeutics Inc. LOW The post-print drift has continued without repair: the 2026-08-28 close of $5.92 sits two cents above the $5.90 shelf the prior note named as the break, with RSI(14) at 21.8 and no Abeona press release at all between 2026-08-13 and… ABNB Airbnb, Inc. LOW Airbnb’s post-Q2 growth re-rating failed its published $175 weekly-close test on September 11, 2026, when shares closed at $170.19. The remaining operating case turns on Q3 revenue meeting the August 6 guidance floor of $4.69 billion. ACB Aurora Cannabis Inc. fresh LOW Aurora Cannabis's takeover thesis requires improved Curaleaf terms or a competing definitive offer before a weekly close below $3.40. Curaleaf's 2026-09-14 regulatory application advances the dispute, but its 2026-09-15 letter retained… ACDC ProFrac Holding Corp. fresh LOW ProFrac's frac-pricing recovery has September financing relief, but operating confirmation is missing. The case requires Q3 stimulation margin above the 9% reported on 2026-08-06 and a weekly close above the August reference of $5.37… ACHC Acadia Healthcare Company, Inc. fresh LOW Acadia Healthcare's turnaround case requires confirmation of its 2026-07-28 earnings outlook and a weekly recovery above $30.20 before a weekly close below $27. The 2026-09-18 close of $28.33 leaves recovery unconfirmed despite the latest… ACHR Archer Aviation Inc. LOW Archer Aviation’s acquisition-led recovery thesis failed when the 2026-09-11 weekly close of $5.58 breached its published $5.65 threshold. Completion of the Boeing transaction remains the business test, but cannot reverse that price… ACLS Axcelis Technologies, Inc. fresh LOW Axcelis has stopped falling without being re-bid: $115.57 on 2026-08-28 to $115.08 on 2026-09-04, RSI(14) down to 22.0, 39.9% under the $191.6 high. What is left is a de-rated implant franchise plus an undated China SAMR ruling into the… ACMR ACM Research, Inc. fresh LOW The base break published 2026-08-16 has held without extending: the 2026-09-04 close of $74.44 is two cents above the 2026-08-28 weekly close and still under the $76.29 June base low close, with RSI(14) down to 32.8 and no company-dated… ACN Accenture PLC fresh LOW Accenture's recovery depends on enterprise AI work supporting growth. The case requires fiscal 2027 local-currency growth guidance starting at 3% or higher on 2026-10-01 and a daily close above $189.61 by 2026-10-14, before a daily close… ADSK Autodesk, Inc. fresh LOW Autodesk’s AI and asset-operations expansion supports a residual recovery case after its conference failed to restore price confirmation. A weekly close above $250 before a weekly close below $205 would confirm that case; the 2026-09-18… ADTN ADTRAN Holdings, Inc. fresh LOW ADTRAN Holdings’ optical-led margin recovery needs Q3 revenue of at least $295.0 million and non-GAAP operating margin of at least 5.5% to establish recovery. September product headlines renew attention, but a weekly close below $7.00… AEIS Advanced Energy Industries, Inc. LOW Datacenter-power picks-and-shovels re-rating is now fully mainstream — Morgan Stanley initiated Overweight $421 (07-22) atop Wells $465 and Susquehanna $535 — yet the stock fell 12.65% on 07-02 and is sitting on its 200-day while analyst… AEM Agnico Eagle Mines Ltd. LOW Agnico Eagle Mines’ gold-driven cash generation supports a recovery case, tested by the September 16 Fed decision. A weekly close above the market’s August 28 reference close of $206.25 establishes recovery before a weekly close below $199… AFRM Affirm Holdings, Inc. fresh LOW The +80%-off-March recovery re-rate has matured and rolled over: Morgan Stanley pulled its Overweight ('valuation call') on 2026-06-25, and price faded ~30% from the $100 high back onto the reclaimed 200-day near $70 while targets stayed… AGL agilon health, inc. fresh LOW agilon health’s re-rating depends on Q3 confirming margin repair after its September partnership expansion. Medical margin of at least $105 million with the annual outlook intact would validate the operating case; a weekly close below $80… AGX Argan, Inc fresh LOW AI-data-center gas-EPC theme still accelerating (4.1+ GW gas backlog, $973.6M cash, zero debt), but AGX has round-tripped from the $805.75 ATH to $563, losing both the ~$675 breakout and ~$600 shelves. Mean reversion toward the pre-run… AGYS Agilysys, Inc. fresh LOW Hospitality vertical-SaaS recovery has re-accelerated into its print: AGYS ran ~+18% to $108.98 (2026-07-10) off the June ~$92 base, clearing the two lowest analyst targets ($100/$110) ahead of a confirmed 2026-07-27 Q1 FY2027 binary that… AIP Arteris, Inc. fresh LOW Q2 (2026-08-06) beat and raised — revenue $24.1M +46%, TTM variable royalties $8.6M +65%, FY26 guide lifted to $95-98M — and the stock still closed $28.32 on 2026-08-14, 41.7% under the 6/30 high. The $33 weekly break fired while the… AIRO AIRO Group Holdings, Inc. LOW AIRO Group Holdings’ recovery case rests on drone backlog conversion after the September tariff narrative failed. A Nord Drone closing by 2026-09-30 and a weekly close above the broken $8.00 level would establish the near-term case; a… AKBA Akebia Therapeutics, Inc. fresh LOW VOICE outcomes win (USRC trial stopped early, June 2026) de-risked Vafseo's dialysis-anemia case, but the tape bled to ~$1.22, only ~48% above the $0.82 low and still fading; the late-July/early-August Q2 print is the binary —… AKTS Aktis Oncology, Inc. LOW Aktis Oncology's radiopharmaceutical story needs September conference attention to restore the August breakout. A weekly close above the 2026-08-28 close of $25.78 would confirm recovery, while a weekly close below $22 would invalidate the… ALGM Allegro MicroSystems, Inc. fresh LOW The June AI data-center power-attach re-rate has flipped from being marked up to marked down: TD Cowen cut its target to $66 (2026-07-13) and Barclays downgraded to Equal-Weight at $48 (2026-07-20), the first target below the June range —… ALHC Alignment Healthcare, Inc. fresh LOW Profitable-MA-disruptor narrative broke on 2026-07-08: a whistleblower suit from a former Chief Transformation Officer alleges the +88% adjusted-EBITDA inflection was manufactured by reclassifying opex as capex across FY2024-25. Shares… ALK Alaska Air Group, Inc. LOW Alaska Air Group’s recovery case depends on restored guidance on 2026-09-29 and a weekly close above $47 by the estimated 2026-10-22 results. A weekly close below $38 or Investor Day passing without a full-year framework invalidates the… ALKS Alkermes plc LOW Alkermes plc's orexin sleep-drug expansion needs supportive clinical data and a weekly close above $49.17 to confirm recovery. A weekly close below $44 invalidates that case as the estimated 2026-09-30 ALKS 7290 window approaches. ALLE Allegion Public Limited Company LOW Allegion’s electronic-access growth story failed its published price test when the 2026-09-11 weekly close of $153.35 breached $154. The continuation thesis is invalidated; the operating growth case remains unconfirmed after management’s… ALMS Alumis Inc. fresh LOW The lupus leg is gone: LUMUS missed BICLA at Week 48 and every secondary in the overall 408-patient population on 2026-09-01, and the stock closed 2026-09-04 at $11.10 with RSI(14) at 18.2, 63.4% below the $30.30 high. What is left is a… ALNT Allient Inc. fresh LOW Record-orders story intact — Q2 2026 bookings $201.3M (+49% YoY), 1.31x book-to-bill, backlog $298.0M — but the supply picture changed after the note: the CEO's trusts sold 70,000 shares at $112.49–$115.765 on 2026-08-10 and 13D holder… ALTO Alto Ingredients, Inc. LOW Ethanol-to-specialty/low-carbon pivot re-rated ~6x off $0.92, but both fuel catalysts — the June 45Z cash sale and the Russell index add — are spent, and price has round-tripped from the $6.11 July high to ~$4.64, losing the $5.10-$5.20… AMAT Applied Materials, Inc. LOW Applied Materials' recovery case is that equipment earnings can restore a weekly close above $492.32 before a weekly close below $437 invalidates it. The 2026-09-11 close of $456.49 leaves the August price structure unrepaired after the… AMBQ Ambiq Micro, Inc. fresh LOW Q2 (2026-08-11) net sales $33.9M, +89.7% YoY and a $36–37M Q3 guide above the $34.0M Street have bought nothing: the 2026-09-04 close of $57.45 sits 36.5% under the $90.48 high with RSI(14) at 31.7. A Form 4 filed 2026-09-02 shows the CEO… AMKR Amkor Technology, Inc. fresh LOW A second anchor — the $1.5B Nvidia advanced-packaging/test partnership (2026-07-23) stacked on the 2026-06-16 TSMC 10-yr Arizona deal — is re-rating Amkor from single-customer Apple OSAT toward US AI back-end anchor. But every catalyst… AMN AMN Healthcare Services fresh LOW Healthcare-staffing cyclical recovery, real but maturing and now at the highs: ~$32.9 (2026-07-24), just off a fresh 52-wk high $36.27 (~+120% off $14.87). Truist's 2026-07-22 lift to a Street-high $40 Buy is the first target leading… AMP Ameriprise Financial, Inc. fresh LOW Ameriprise Financial’s wealth-platform recovery requires a weekly close above $553.46 and third-quarter client flows above $3.1 billion before a weekly close below $540 invalidates it. Huntington’s planned October transition supplies the… AMPL Amplitude, Inc. fresh LOW Amplitude's AI analytics reacceleration case needs improving customer retention and recovery above the August $14.30 high. A weekly close below $12.60 invalidates the price case; the next quarterly report tests retention against the 103%… AMRX Amneal Pharmaceuticals, Inc. LOW Amneal Pharmaceuticals’ specialty-and-biosimilar revaluation needs price confirmation alongside intact annual guidance. The case resolves with a weekly close above the $19.10 reference high before a weekly close below $16.50; Leerink’s… AMSC American Superconductor Corporation LOW Grid/advanced-conductor supplier to data-center and utility power; backlog still ~+40% YoY (~$280M), but the tape broke after the 2026-05-28 beat-and-soft-guide and a late-June Russell removal piled on passive selling. Below the lost ~$40… AMZN Amazon.com, Inc. LOW Amazon's cloud-growth recovery case depends on earnings validating its infrastructure spending and price reclaiming the August record. A weekly close above $284.02 completes the price case; a weekly close below $245 invalidates it, with… ANAB AnaptysBio, Inc. fresh LOW AnaptysBio’s Jemperli rights-reversion thesis turns on a written Chancery judgment; the September 25 brief advances the case without settling it. A judgment granting reversion before a weekly close below $52 would establish the thesis… ANRO Alto Neuroscience Inc. fresh LOW Alto Neuroscience’s funded depression-trial program supports a recovery case, but September price weakness lowers conviction. A weekly close above $36.64 would establish recovery before a weekly close below $28 invalidates it; PACE-2 must… AOSL Alpha and Omega Semiconductor Limited fresh LOW Post-parabola digestion. The Apr–May "second-order AI power-semi" re-rate (~3x to $54.34) is fully priced, above the $30.50 consensus PT with no fresh company catalyst in 11+ weeks; the 2026-07-15 pop was a newsletter-driven volume spike,… APH Amphenol Corporation LOW AI-interconnect content leg unchanged since the 2026-07-29 print — orders $10.7B, book-to-bill 1.23:1, Q3 guided above consensus — but the bid has not come back: $157.74 on 2026-08-28 is flat on the week while RSI(14) slid from 43.4 to… APLD Applied Digital Corporation LOW Applied Digital's recovery rests on contracted AI capacity becoming recurring rent. The case requires fiscal Q1 2027 rental revenue above Q4's $50.6 million and a weekly close above the $28.23 August shelf before a weekly close below $24… ARCT Arcturus Therapeutics Holdings Inc. LOW Arcturus Therapeutics’ regained vaccine rights underpin a revaluation thesis that requires ARCT-810 data and a stated regulatory development path by 2026-09-30. Missing that disclosure boundary or a weekly close below $12 invalidates the… AREC American Resources Corporation LOW American Resources Corporation’s critical-minerals refining thesis breached its published $2.40 weekly price test on 2026-09-11. Recovery above that level and filed evidence of commercial value reaching the parent would be needed to… ARES Ares Management Corporation LOW Ares Management’s fee-growth story faces a price-confirmation test after the 2026-09-11 close of $131.64. A weekly close above the September 4 reference of $140.15 before a weekly close below $130 would complete the recovery case; another… ARHS Arhaus, Inc. LOW Arhaus's order-recovery thesis requires Q3 2026 delivered-sales growth above Q2's 4.0% and a weekly close above the lost $9.00 market shelf. A weekly close below $8.00 invalidates the case. ARTV Artiva Biotherapeutics, Inc. fresh LOW Artiva Biotherapeutics’ AlloNK thesis hinges on expanded rheumatoid arthritis data and pivotal-trial initiation by year-end 2026. Those milestones must arrive before a weekly close below $8.61 invalidates the market case. ASML ASML Holding N.V. LOW ASML's September customer agreements reopen its lithography growth story, but the price recovery remains unconfirmed. A weekly close above $1805 by 2026-10-14 and third-quarter sales meeting July guidance would establish the case; a weekly… ASTS AST SpaceMobile, Inc. LOW AST SpaceMobile’s spectrum-access recovery requires a disclosed Grain agreement and a weekly close above $62.40 by 2026-11-05. A weekly close below $55.74 would invalidate the case first. ASX ASE Technology Holding Co., Ltd. fresh LOW Advanced-packaging pricing power is real — quotes raised 20%+ (2026-07-01), 2026 capex hiked to US$8.5B, CoWoS-equivalent capacity tripling to 25k wpm — but the tape topped at $45.51 the same day and sits ~15% lower inside a 13% semi… ATEN A10 Networks Inc fresh LOW AI-security re-rate off the 2026-06-15 TrojAI deal has stalled: ATEN churning ~$35 below the $37.36 ATH, momentum cooling as Mizuho lifts its target to $34 but stays Neutral — analyst catch-up, not fresh conviction. The 2026-08-05 Q2 print… ATHM Autohome Inc. fresh LOW No company disclosure since the 2026-08-20 print; what moved is the research around it — Citi lifted its target from $17 to $22 on 2026-08-24, Goldman from $19 to $21, and consensus now reads $21.44, below the 2026-09-04 close of $22.03.… AU AngloGold Ashanti plc fresh LOW AngloGold Ashanti’s gold-margin rally thesis failed when its 2026-09-18 weekly close of $103.29 breached $105. A separate recovery case requires a weekly close back above $105 and production confirmation at the 2026-11-05 results. AUGO Aura Minerals Inc. fresh LOW Gold/copper producer basing $53–$76 under a broken ~$72 shelf after a ~45% fall from the $110 high. Q2 output slipped 8% QoQ — first sequential drop after a record Q1 — as gold cools to the low-$4,000s and sell-side keeps trimming (JPM to… AUTL Autolus Therapeutics plc LOW Autolus Therapeutics’ AUCATZYL growth story lost price confirmation when the 2026-09-11 close breached the published $2.05 weekly threshold. A recovery case requires a weekly reclaim above $2.05 and delivery against the $140–150 million… AVGO Broadcom Inc. LOW Broadcom’s custom AI ramp supports an earnings-recovery thesis if Q4 AI revenue meets its $21.7 billion guide at the planned 2026-12-09 report and shares reclaim $370 before a weekly close below $340. The September 11 close of $361.99… AVLN Avalyn Pharma Inc. fresh LOW Avalyn Pharma’s inhaled-antifibrotic re-rating depends on recovering the September 4 market close of $37.39 before a weekly close below $30. The September 8 modeling release left clinical efficacy unresolved ahead of MIST results guided to… AVR Anteris Technologies Global Corp. fresh LOW Post-catalyst drift: the CMS/first-patient/France de-risking sequence is spent, and Q2 (reported 2026-08-12) missed both lines — EPS $(0.30) vs $(0.21), revenue $1.009M vs $1.500M — yet the 2026-08-14 close held $9.40 with RSI 66.9.… AVTX Avalo Therapeutics, Inc. fresh LOW Avalo Therapeutics' abdakibart recovery case rests on funded Phase 3 development; fuller LOTUS data and a weekly close above the September 4 reference of $19.23 would confirm it. A weekly close below $16 invalidates the case. AVXL Anavex Life Sciences Corp. LOW Anavex Life Sciences’ governance rerating thesis failed its price test: the 2026-09-11 close of $2.62 breached the published $2.75 weekly threshold. The 2026-09-24 board vote still settles control, but it cannot reverse that recorded… AXTI AXT Inc LOW AXTI's contracted-InP leg is intact on paper with no price expression: the 2026-09-02 close of $56.95 reclaimed neither the $58 line lost 09-01 nor April's $64.25 placement shelf lost 08-28, and no AXT release or filing is dated later than… AZTA Azenta, Inc. LOW Azenta's cash-backed operating recovery needs positive organic growth at the next results and a weekly close above the August shelf at $32.04. The September 11 close of $30.85 leaves confirmation outstanding; a weekly close below $28… AZZ AZZ Inc. LOW Beat-and-raise fired 2026-07-08 — Q1 adj EPS $1.85 vs $1.69, FY27 guide lifted twice on Metal Coatings momentum — but the catalyst is now behind the stock, which sits at all-time highs (~$157), ~23x forward and above consensus, with Wells… BABA Alibaba Group Holding Limited fresh LOW Alibaba's cloud revaluation depends on Qwen commercial terms at the September 22–24, 2026 Apsara Conference and recovery above the $118.90 market shelf. The case fails on a weekly close below $112 or if the conference ends without those… BAK Braskem S.A. fresh LOW Braskem's restructuring recovery depends on a binding parent plan that preserves listed equity without creditor-driven dilution. The 2026-09-24 subsidiary hearing tests the first agreement; the estimated 2026-11-22 parent creditor-support… BAND Bandwidth Inc. fresh LOW Late-stage small-cap CPaaS squeeze: +360% YoY into the mid-$70s, ~5% below the $79.08 high, with Citizens ($86, 2026-07-20). Riley ($85) both lifting targets in July. A confirmed Q2 print on 2026-07-29 is a binary two trading days out —… BAX Baxter International Inc. fresh LOW Baxter International's turnaround re-rating failed its published $24 weekly-close test when the shares closed at $23.80 on 2026-09-11. The operating-recovery premise remains unconfirmed by repeatable earnings improvement. BBBY Bed Bath & Beyond, Inc. LOW Lemonis "Everything Home" roll-up keeps closing deals — Container Store now wholly owned (2026-07-08), TwoPonds folded in (2026-07-01) — but the tape has bled from $5.83 to ~$4.96 and sits on the $4.26 52-week low as shares balloon past… BBY Best Buy Company, Inc. LOW Tape flipped since early July: BBY broke to a fresh 52-week high $87.35 (~$85.41 on 2026-07-17, +27.6% YTD) on RGB-LED TV exclusivity plus an AI-PC/MacBook refresh cycle. But price sits ~8% above the $79.15 consensus target while Loop… BCAX Bicara Therapeutics Inc. LOW Bifunctional EGFR/TGF-β narrative in HPV-negative head & neck cancer stalled after the ASCO 2026 three-year-OS re-rate: $27.76 close is ~10% off the $30.99 high on roughly half prior turnover, consensus PT ~$31.46 sits only 13% above spot,… BEEM Beam Global LOW Beam Global’s battery pivot needs revenue conversion: Q3 revenue matching $8.562 million, backlog above $5.4 million and quantified battery revenue would confirm the case. A weekly close below $1.20 invalidates the market thesis. BH Biglari Holdings Inc. LOW Biglari Holdings’ re-rating case depends on sustained Steak n Shake earnings improvement and recovery of the lost price shelf. Confirmation requires third-quarter pre-tax operating earnings above Q2’s $6,274 thousand and a weekly close… BHC Bausch Health Companies Inc LOW The post-print round trip is complete: the 2026-07-29 beat-and-raise (adj EPS $1.26 vs $1.04 consensus) carried BHC to a $7.90 high and the 2026-08-28 close of $6.32 handed all of it back. What is left is roughly $2.4B of equity on… BHVN Biohaven Ltd. LOW Biohaven's recovery case rests on SK licence funding and removal of the opakalim enrollment hold. Completion of both and a weekly close above $14 would establish recovery; a daily close below $12.71 invalidates it, while the earlier… BIDU Baidu, Inc. ADS LOW The last dated event in a flow-mechanical leg lands 2026-09-07: southbound Stock Connect eligibility for the Hong Kong counters that turned dual-primary on 2026-09-01. The ADR closed $95.58 on 2026-09-03, -41.2% from the $162.52 high, with… BIOA BioAge Labs, Inc. LOW BioAge Labs' recovery hypothesis links September 8 clinical progress to a weekly reclaim of $9.00 before a weekly close below $8.49. The prior shelf thesis failed on September 11; QUELL-CV results remain the next test of biomarker efficacy. BIRK Birkenstock Holding plc LOW Birkenstock Holding plc’s raised earnings outlook supports a fragile recovery case, resolved by a weekly reclaim above $36 before a weekly close below $31. The September 11, 2026 close of $31.13 leaves that case unconfirmed. BJRI BJ's Restaurants, Inc. fresh LOW BJ's Restaurants' traffic-led reset needs price recovery and confirmation of its raised sales outlook. A weekly close above the $60.77 pre-results shelf plus third-quarter confirmation of fiscal 2026 comparable-sales guidance would… BKNG Booking Holdings Inc. fresh LOW Booking Holdings’ repurchase-led earnings story has failed its published $188 weekly price test: the 2026-09-18 adjusted close was $167.90. A separate recovery case requires a weekly reclaim of $188 and Q3 room-night and revenue growth… BKSY BlackSky Technology Inc. fresh LOW Gen-3 subscription ramp landed in Q2 (2026-08-06): revenue $33.316M vs $30.68M est, +50% YoY, adjusted EBITDA $4.7M, FY26 guide affirmed at $130–150M. But EPS missed at $(0.54) vs $(0.36), cash is $36.9M against a $50–60M capex guide, and… BLDP Ballard Power Systems, Inc. fresh LOW Ballard Power Systems’ GeoPura pivot needs reported growth to reverse a broken price structure. The recovery case requires next-quarter revenue above Q2’s $20.6 million, backlog of at least $156.6 million and a weekly close above the… BLKB Blackbaud, Inc. LOW Blackbaud’s repurchase-led recovery needs sustained 3.0% organic growth and a weekly close above $47.52 by Q3 results. The $45.48 close on 2026-09-11 leaves that case unconfirmed; a weekly close below $44 invalidates it. BLMN Bloomin' Brands, Inc. fresh LOW Bloomin' Brands' margin-repair story supports only a tentative price recovery after its August advance failed. A weekly close above the September 4 reference of $9.79 would establish recovery; a weekly close below the September 18… BNGO Bionano Genomics, Inc. fresh LOW Bionano Genomics’ clinical-adoption and reimbursement story supports a test of the $2.13 annual high. A daily close above that level would confirm the price case; a weekly close below the September 18 reference close of $1.73 would… BRBR BellRing Brands, Inc. fresh LOW BellRing Brands’ tentative recovery case rests on October pricing supporting a weekly return above the lost $10 threshold before full-year results. The prior base has failed; a subsequent weekly close below the September 18 reference close… BRKR Bruker Corporation fresh LOW Post-ASMS instrument re-rate broke back toward the $64.54 high and added a second leg: semiconductor-metrology strength (orders +20% YoY) pulled Leerink to $70 and top targets to $65–70. But at ~$62 the name sits ~13% over its 50-DMA and… BROS Dutch Bros Inc. LOW Drive-thru coffee comps re-accelerating (Q1 +8.3%, FY guide raised) and the sell-side is now catching up — Stephens initiated Overweight $80, Morgan Stanley to $88 in mid-July. But June's run to ~$72 cooled to the mid-$60s, and the… BSIN Big Sky Industrial Inc. LOW Big Sky Industrial's helium-and-carbon pivot must produce first helium revenue in Q1 2027 and secure carbon monitoring approvals. The timetable disclosed on 2026-08-11 defines the case; a weekly close below $1.30 or a disclosed delay… BTBT Bit Digital, Inc. fresh LOW Both legs of the wrapper are now rolling over: WhiteFiber (WYFI, ~70.5% owned) de-rated from $38.50 to $27.57 as the June neocloud mania cooled, and BTBT slid to ~$1.50, a step above its $1.25 low. SOTP discount still ~49% (~$745.6M WYFI… BTDR Bitdeer Technologies Group fresh LOW Spring miner-to-AI re-rate has fully unwound: BTDR lost the $15 shelf to $12.56 (2026-07-09) as AI-cloud ARR plateaued at ~$69M for a 2nd month. A signed-but-not-effective Tydal colocation lease (2026-06-29) and a $36M Nevada plant are the… BTE Baytex Energy Corp. fresh LOW July's Hormuz flare re-armed the oil-geopolitical premium, but it has since drained — WTI slipped to the low $70s and the 2026-07-17 sanctions wind-down passed with no barrel shortage, a contained-conflict bid rather than a supply shock.… BTGO BitGo Holdings, Inc. LOW Broken IPO that cleared its 2026-07-21 lockup without a supply flood but is grinding on the $4.665 all-time low with no bounce; Goldman cut its target to $7.75, and the undated $100M Galaxy verdict plus the ~2026-08-26 Q2 print are the… BVS Bioventus Inc. LOW Bioventus's acquisition-review thesis requires a definitive acquisition agreement above the 2026-09-11 close of $12.98 before a weekly close below $12.50. The August 5 proposal disclosure supports the case, but the review has no deadline… BWIN The Baldwin Insurance Group, Inc. LOW Take-private premium is bleeding while sell-side chases it higher: price slipped to $27.25 (2026-07-17) from $28.41 (2026-07-02) even as KBW went to $31 and JPM to $30. Nothing is signed, and the 2026-07-30 Q2 print (guide $485–490M,… CABA Cabaletta Bio, Inc. fresh LOW Autoimmune CD19 CAR-T reset story, now funded — $225.1M cash at 2026-06-30, runway into mid-2027 — but registrational RESET-Myositis data are guided to mid-2027 and the BLA to 2H27, so no clinical datapoint resolves inside 30 days.… CACI CACI INTERNATIONAL CLA fresh LOW CACI International's defense-technology re-rating requires a weekly recovery above $646 and reaffirmed fiscal 2027 guidance at the next results. A weekly close below $600 would invalidate the recovery case. CADL Candel Therapeutics, Inc. fresh LOW Candel Therapeutics’ recovery case requires a weekly reclaim of $11.80 and its planned Q4 2026 prostate-cancer filing before a daily close below $10.85. The September 18 close already invalidated the previous momentum thesis. CAI Caris Life Sciences, Inc. fresh LOW Caris Life Sciences’ molecular-profiling growth supports another revenue-guidance increase at the next quarterly report. Guidance above the 2026-08-05 upper bound of $1.040 billion would confirm the case; a weekly close below $22 would… CAKE Cheesecake Factory Incorporated (The) fresh LOW Casual-dining re-rate got a genuine second leg: Citi's 2026-07-10 raise to a street-high $90 (Buy) on a rewards/app traffic-inflection thesis gapped shares 7% to all-time highs (~$86, 52wk high $86.66 on 2026-07-18). For the first time the… CAL Caleres Inc fresh LOW Q2 was pulled forward one day to 2026-09-09 (announced 2026-09-01), compressing the read into a single session: FY2026 consensus of $1.62 adjusted EPS sits at the top of the company's own $1.40–$1.65 guide, Famous Footwear is guided down… CARG CarGurus, Inc. LOW CarGurus’ margin-improvement and repurchase story failed its published $35 weekly price test at the September 11, 2026 close of $34.42. Third-quarter results can distinguish operating weakness from price deterioration, but cannot undo that… CBRL Cracker Barrel Old Country Store, Inc LOW Cracker Barrel's turnaround thesis failed its $50 weekly-close test at the $49.48 close on 2026-09-11. The confirmed 2026-09-23 results will test July's strengthened operating outlook, but cannot reverse the recorded price invalidation. CCJ Cameco Corporation LOW Nuclear-uranium theme maturing and CCJ's structure has broken twice into improving news: mkt cap $44.79B (06-29) → ~$39.9B (07-25), ~$88, ~35% off the $135.24 high, absorbing a $17.5B federal AP1000 program and NJ's $24B plan. Barclays cut… CCS Century Communities, Inc. LOW Century Communities’ entry-level housing recovery thesis failed its $65 weekly price test at the 2026-09-11 close of $60.54. A renewed case requires a weekly close above $65 and company results sustaining year-over-year order growth and… CCXI Churchill Capital Corp XI fresh LOW De-SPAC humanoid pure-play still bleeding premium: $17.07 (2026-08-14) → $14.57 (2026-08-21) → $13.40 (2026-09-04), RSI(14) down to 25.9. The only company-dated item since the 2026-07-14 confidential S-4 is an 2026-08-27… CDNL Cardinal Infrastructure Group Inc. fresh LOW Post-blowoff digestion is deepening: the ~4x data-center site-work roll-up has bled from a $96 high back to its $63 average analyst target, now below the $73 secondary price and the 50-DMA. Q1 organic +64% and an $854M backlog keep… CDW CDW Corporation fresh LOW Second-order AI-server reseller whose ~37% recovery off the $97 low has stalled: a mid-July push to $144 round-tripped to $133 by 2026-07-17, right in the fairway of the ~$145 consensus target. The re-rate (JPM, MS $170, Citi $145) is… CECO CECO Environmental Corp. fresh LOW 2nd-order AI-power name — Q1 orders +97% YoY and a first-ever >$1B backlog (2026-04-28) feed the datacenter/electrification capex wave, and the closed Thermon merger doubled EBITDA. But price rolled over ~25% off the $101.24 ATH to $75.63,… CEG Constellation Energy Corporation LOW Constellation Energy's nuclear-contract recovery requires additional signed capacity and a weekly close above $290.04. The September 11 close of $284.75 preserves the reclaimed band, but a weekly close below $281 would end the thesis. CERS Cerus Corporation fresh LOW Two lower weekly closes now sit under the broken $2.70 shelf — $2.65 on 2026-08-28, then $2.59 on 2026-09-04 — with RSI(14) at 24.3 and an empty news tape behind the decline. The operating record is unchanged (FY26 product guide $229–231M,… CEVA CEVA, Inc. fresh LOW Edge-AI IP momentum leg has broken: June's reclaim to within ~3% of the $51.60 high failed, and the mid-July AI-capex scare (Moonshot model) drove shares back through the ~$44 base to the mid-$30s. Sell-side still carries $48–$55 targets,… CGC Canopy Growth Corporation fresh LOW The rescheduling binary CGC trades on came and went: the DEA hearing closed 2026-07-15 with no verdict, briefs due 2026-08-17 and the ALJ recommendation undated into H2 2026, likely litigated into 2027. Shares closed $0.89 on 2026-07-24,… CHYM Chime Financial, Inc. fresh LOW Busted-IPO fintech: operations accelerating (Q1 rev +25% to $647M, first GAAP profit, FY guide raised to $2.66–2.69B) but the stock trades ~19% below its $27 IPO and bases near post-IPO lows — a compressed multiple, not an accelerating… CIEN Ciena Corporation LOW The 1.6T WaveLogic demand cycle is intact at the order book, but the trade has broken: $627.00 (06-02) to ~$370 (07-18) is a ~41% de-rating, and the $455–$467 shelf that framed the prior read is gone. Multiple compression from 54x forward,… CLDX Celldex Therapeutics, Inc. LOW Celldex Therapeutics’ barzolvolimab case requires both Phase 3 CSU trials to meet their primary efficacy endpoints by 2026-10-31 before a weekly close below $35. The 2026-09-11 close of $36.90 leaves the structural case unresolved ahead of… CLFD Clearfield, Inc. fresh LOW The May earnings-miss squeeze has fully round-tripped to a dead tape in the mid-$30s, below the ~$36 gap base, with the retail-sentiment narrative spent. The sole live driver is the 2026-08-05 fiscal-Q3 print — guided to a sharp sequential… CLPT ClearPoint Neuro, Inc. fresh LOW Picks-and-shovels delivery play on CNS gene therapy: ClearPoint's SmartFlow cannula and MRI navigation are the standard route to the brain for uniQure's AMT-130 Huntington's BLA (soft Q3-2026 window). The June re-rate held near $18.72… CLS Celestica, Inc. fresh LOW AI-datacenter EMS picks-and-shovels story still fundamentally climbing after the 2026-04-27 Q1 crush (rev +53% to $4.05B, FY26 guide raised to $19B), but the tape broke ~21% off its $474 June high and heads into a binary 2026-07-27 Q2… CLW Clearwater Paper Corporation LOW Clearwater Paper's paperboard recovery depends on September extending August's pricing increase and third-quarter earnings meeting guidance. The case requires another SBS assessment increase and $20–30 million of third-quarter adjusted… CMG Chipotle Mexican Grill, Inc. LOW Chipotle Mexican Grill's expansion-led recovery needs positive third-quarter traffic and a return above $38.52 by 2026-10-28. The 2026-09-11 close of $36.20 weakens that case; a weekly close below $35 or negative third-quarter transaction… CNMD CONMED Corporation fresh LOW CONMED Corporation's sale-premium thesis failed its published $46 weekly-close test on 2026-09-18. A disclosed transaction would establish a new deal case; September operating commentary has not resolved the July sale report. COCO The Vita Coco Company, Inc. LOW The Vita Coco Company's growth-to-margin thesis failed its $60 weekly price test at the 2026-09-11 close of $52.01. A recovery above that shelf and quantified freight-cost guidance would reopen the case; the 2026-09-16 conference is the… CODI Compass Diversified LOW Compass Diversified’s asset-sale and debt-reduction story needs operating confirmation and recovery toward B. Riley’s $15 target before a weekly close below $11 breaks the thesis. The 2026-09-11 adjusted close of $11.01 leaves the existing… COMP Compass, Inc. LOW Now stretched into a binary ~2026-07-29 Q2 print ($4.0–4.2B guide) with an open NY AG antitrust probe. CORT Corcept Therapeutics Incorporated LOW Lifyorli oncology launch (approved 2026-03-25, NCCN preferred) re-accelerated the tape to fresh 52-week highs near $92, and the 2026-06-17 Cushing's relacorilant resubmission (~Dec PDUFA) adds second-approval optionality. But a fresh entry… CPIX Cumberland Pharmaceuticals Inc. LOW Cumberland Pharmaceuticals’ post-Apotex recovery depends on ifetroban results restoring clinical credibility. The case requires disclosed endpoint results followed by a weekly close above the September 11 high of $8.97 before a weekly… CRCT Cricut, Inc. LOW Cricut’s platform transition now has Maker 5 behind it; the next quarterly report must show growth in both segments before a daily close below $5.16 breaks the case. The 2026-09-03 launch satisfies the earlier announcement condition but… CRL Charles River Laboratories International, Inc. fresh LOW Charles River Laboratories’ demand-recovery continuation thesis was invalidated by the 2026-09-18 weekly close of $278.06 below $280. The 2026-09-24 Investor Day tests the operating framework but cannot undo that breach. CROX Crocs, Inc. fresh LOW Legacy-brand turnaround with the raised guide intact and the tape still unwinding: after the 2026-07-30 beat-and-raise (FY2026 adj EPS $13.70–$14.00), closes went $131.72 (08-14) → $122.11 (08-21) → $117.53 (09-04), RSI(14) 26.9, -16.8%… CRS Carpenter Technology Corp fresh LOW Aero-defense superalloy pricing cycle intact (three contracts at >30% hikes; Q4 op-income guide $205-210M, +37% YoY), but the July flush to $532 has been bought back to ~$603 straight into the 2026-07-30 Q4 print — now four sessions out… CRTO Criteo S.A. LOW Criteo's recovery case rests on ChatGPT advertising translating into financial stabilization. Q3 contribution excluding traffic acquisition costs reaching $241 million without another annual outlook cut would validate it; a daily close… CRVS Corvus Pharmaceuticals, Inc. LOW Corvus Pharmaceuticals’ soquelitinib recovery case requires a weekly close above the August 28 close of $14.16 before a weekly close below $12.50. Angel’s eczema results, guided on August 6 to late 2026, remain the next clinical test;… CSCO Cisco Systems, Inc. LOW Legacy-networker AI re-rate intact and now at its binary: the $118–120 shelf held through July, price closed $121.43 on 2026-08-07 with RSI(14) at 78.4, and five sell-side target raises landed 07-22 → 08-06 (Citi $112→$139) ahead of the Q4… CSIQ Canadian Solar Inc. LOW Canadian Solar’s recovery thesis rests on domestic-module contract repricing after management’s 2026-08-27 policy discussion. Disclosed price increases and a weekly close above the former $14.00 shelf would establish the case; a weekly… CTSH Cognizant Technology Solutions Corporation LOW Cognizant's enterprise-AI pivot needs third-quarter revenue confirmation and a recovery above the August 28 close of $64.04. Revenue below the July 29 guidance floor of $5.600 billion or a weekly close below $58 would invalidate the case. CVLG Covenant Logistics Group, Inc. LOW The margin-inflection leg broke at its own catalyst: Q2 (2026-07-29) adjusted OR 95.9% vs 94.6% PY — second straight quarter of YoY deterioration — revenue $332.9M missed $340.4M, and Stephens cut its 23-day-old target to $54 on 07-31.… DDD 3D Systems Corporation LOW June's $50M raise at $3.05 (16.4M sh) is already underwater: shares last $2.775 (2026-07-02), below the offering floor, with ~$50M shelf undrawn and soft Q2 guidance (rev $93–95M, adj. EBITDA still negative) into the 2026-08-10 print. A… DDOG Datadog, Inc. fresh LOW June's sell-side upgrade wave has exhausted and the first cut printed — Bernstein to Market Perform (PT $226, 2026-07-06) as the stock rolled over. AI-observability narrative intact but maturing; the $278.71 parabola round-tripped and the… DFTX Definium Therapeutics, Inc. LOW Definium Therapeutics’ recovery thesis turns on September’s Panorama anxiety trial confirming DT120 efficacy and restoring the pre-readout price structure. Success requires a positive primary endpoint and a weekly close above $46.14 before… DIOD Diodes Incorporated LOW The AI-server/auto power-content re-rate that carried DIOD to a ~$126 all-time high (June 18) has round-tripped: a double-top, an analyst downgrade, more insider selling and a sector-wide semi selloff pushed it to ~$96 by July 10, through… DJT Trump Media & Technology Group Corp. LOW Fusion pivot is the leg: the 2025-12-18 all-stock TAE Technologies merger (>$6B, ~50/50 fully diluted) is what's actually being bought, while the crypto-treasury leg was terminated 2026-08-07. The S-4 was still unfiled as of 2026-08-05,… DLTR Dollar Tree Inc. fresh LOW Dollar Tree’s multi-price earnings-growth thesis failed its published $124 weekly-close test at the 2026-09-18 close of $111.96. Renewed support requires a weekly close above $124 and third-quarter comparable-store sales within the 3%–4%… DNTH Dianthus Therapeutics, Inc. LOW Dianthus Therapeutics’ claseprubart re-rating depends on supportive December clinical evidence and a dated pivotal readout. The price case requires a weekly close above $115.96 by 2026-12-31 before a weekly close below $100 invalidates it. DNUT Krispy Kreme, Inc. fresh LOW Krispy Kreme’s refranchising story requires cash generation and lower leverage, but its August recovery thesis was invalidated by the $3.02 weekly close on 2026-09-18 below the published $3.25 threshold. September promotions continued… DRD DRDGOLD Ltd. fresh LOW DRDGOLD’s gold-margin and processing-expansion thesis lost its published price support when the 2026-09-18 close breached $27.50. The continuation case is invalidated; a renewed expansion case requires completed commissioning and reported… DSGN Design Therapeutics, Inc. fresh LOW Design Therapeutics’ frataxin-biomarker thesis depends on its Q4 2026 update establishing a regulatory path for DT-216P2. Supportive FDA feedback and a defined registrational design would substantiate the case; a weekly close below $13.50… DTIL Precision BioSciences, Inc. LOW Precision BioSciences’ hepatitis B gene-editing thesis needs replicated liver-biopsy results by year-end 2026. The case succeeds if additional patients show cccDNA reduction without treatment-limiting safety findings before a weekly close… DUOT Duos Technologies Group, Inc. LOW The pivot is now structural: the rail subsidiary was sold 2026-08-05 (related party — interim CFO owns 50% of the buyer), leaving an edge-colocation operator carrying a 2026-07-16 five-year 10 MW hyperscaler contract worth >$111M. The tape… DXCM DexCom, Inc. LOW CGM leader's recovery has aged from catalyst-pop to an analyst-revision grind — Mizuho $90 (7/15), Truist $87 (7/16) into a ~7% two-day pop to $76.65 — but price is high-$70s still under the 200-EMA and the confirmed July 30 Q2 print is… DXYZ Destiny Tech100 Inc. LOW Destiny Tech100's Anthropic listing story supports a low-conviction recovery case after the reported timetable slipped. A daily close above the August 28, 2026 close of $34.74 before a daily close below $29.50 would satisfy its price test. EDIT Editas Medicine, Inc. fresh LOW Editas Medicine's EDIT-401 recovery thesis failed its published price test when the 2026-09-11 weekly close reached $2.70, below $2.75. The company's Q1 2027 data-update guidance leaves human lipid lowering unresolved; the market failure… EFOR Everforth, Inc. LOW Everforth's AI-services re-rating needs Q3 2026 revenue above Q2's $1,007.0 million and consulting book-to-bill of at least 1.2 to 1. A weekly close below $28.50 breaks the price thesis before that operating confirmation. ELVN Enliven Therapeutics, Inc. LOW Enliven Therapeutics’ re-rating case depends on starting the pivotal ELVN-001 trial within its guided second half of 2026. Disclosed initiation and a weekly close above the $61.15 high recorded on 2026-09-11 would confirm the case before a… ELVR Elevra Lithium Limited LOW The August leg failed at the print: the ADR closed $59.09 on 2026-08-28 versus $67.76 on 2026-08-21, even as the FY26 report guided FY27 production to 198,000–210,000 dmt against FY26's 197,967 dmt and GFEX carbonate settled CNY 158,700/t… ENOV Enovis Corporation LOW Post-Colfax orthopedic pure-play turnaround: LimaCorporate integration plus FCF-conversion recovery (43% in 2024 toward a 70–80% target) is the self-help story, but price has rolled over from $34 toward $27 while three brokers cut targets.… ENPH Enphase Energy, Inc. LOW IQ SST AI-data-center pivot (announced 2026-04-28) that drove a spring squeeze has stalled — stock de-rated ~16% in a month to ~$45 (2026-07-09), sell-side uniformly neutral with PTs on top of price (Susquehanna $45, 2026-07-10), and SST… ENVA Enova International, Inc. LOW Enova International’s credit-growth recovery requires a weekly close above $235.43 and Q3 confirmation of its raised growth outlook and credit resilience. A weekly close below $223 invalidates the case before that confirmation. EOLS Evolus, Inc. LOW Evolus’s margin-led re-rating failed its published $8.00 weekly price test at the $7.84 close on 2026-09-11. The business case remains subject to delivery of management’s 2026 revenue guidance of $330–337 million and adjusted gross margin… EPAM EPAM SYSTEMS, INC. fresh LOW Compounder narrative broken on 2026-08-06: FY26 organic constant-currency growth cut to 2.0%–3.0%, Q3 guided to ~1.7% YoY. Price has stalled rather than extended lower ($99.90 close 2026-08-11 vs $97.43 on 2026-08-07), but the AI-native… EPC Edgewell Personal Care Company fresh LOW Edgewell Personal Care's takeover-and-recovery thesis needs renewed deal evidence or confirmed growth to restore the market's $29.50 high. A weekly close above $29.50 would complete the price case; a weekly close below $25 would invalidate… EQNR Equinor ASA fresh LOW European winter gas-security theme re-accelerating; Equinor, the swing Norwegian pipeline supplier, held ~$40 through a Q2 double-miss on a $1.125B buyback bid. ERAS Erasca, Inc. LOW FDA Fast Track for ERAS-0015 in metastatic pancreatic (2026-08-24) landed on 16.4x average volume for a -0.17% close; J.P. Morgan then marked to a street-high $33 on 2026-08-27 while the 2026-08-28 close was $18.03 against a $23.5… ERO Ero Copper Corp. fresh LOW Ero Copper's copper-growth re-rating now depends on operating delivery after its September 14 strategy update. A weekly close at or above the prior $40.40 high before a weekly close below $33.80 would establish that the recovery case… EVC Entravision Communication LOW Smadex AI-DSP re-rate broke to a new 52-week high of $13.48 with no dated company news since 2026-07-12 — an anticipatory leg into the 2026-08-10 Q2 print, the binary on whether Q1's +204% ATS growth and ~22% EBIT margin held.… EVER EverQuote, Inc. LOW EverQuote’s insurance-advertising growth thesis needs price confirmation: a daily close above $27.87 before a weekly close below $23.82 would satisfy the price test. Third-quarter revenue below $198 million or adjusted EBITDA below $28… EVH Evolent Health, Inc fresh LOW The late-June retail bounce has fully unwound — EVH traded ~$5.76 on 2026-07-07, back under the $6.59–6.86 consensus target band and well under Truist's flat $7. Nothing carries the name now except the confirmed 2026-08-06 Q2 print, which… EXFY Expensify, Inc. LOW Legacy expense-SaaS pivot re-rated on the 2026-08-06 Q2 print: revenue $33.9M beat $33.688M, paid-member decline halved to -2% YoY, FY26 FCF guide doubled to $12M-$14M, ~7% of shares retired, and New Expensify ARR from net-new customers… EXK Endeavour Silver Corp. LOW Endeavour Silver’s Terronera ramp supports a silver operating-leverage thesis that requires Q3 cost confirmation. The case needs Q3 2026 all-in sustaining cost at or below $30 per silver ounce with annual $27–28 guidance retained before a… EXLS ExlService Holdings, Inc. fresh LOW ExlService Holdings’ AI-services re-rating needs renewed revenue confirmation. A daily close above the August reference close of $37.53 and organic growth guidance of at least 13% would validate the recovery case; a daily close below $34… EXTR Extreme Networks, Inc. LOW Legacy campus-networking name re-rating ~+140% off Feb lows on the Platform ONE / Agent ONE AI-NetOps story plus SaaS ARR +29% YoY; theme still accelerating but spot ($33.71, 07-10) has run through consensus PT $29.06 into the June bull… FAC Factorial Energy Inc. LOW Freshly de-SPAC'd solid-state battery name has fully unwound its debut mania — down ~78% from the $25.33 ATH to ~$5.67, breaking clean through the former $9.26 floor into a fresh 52-week low at $4.24. Cantor's $18 target now sits ~217%… FBIN Fortune Brands Innovations, Inc. fresh LOW Activist-plus-new-CEO turnaround has stopped accelerating and started digesting: after the +30% run off Garden's $40.6 buy, price has chopped $50–54 for three weeks while sell-side targets climbed past spot (Goldman $61 on 7/10, Barclays… FCEL FuelCell Energy, Inc. LOW Street targets re-rated up to the price rather than the reverse: average PT $22.83 across 8 analysts vs the 2026-08-07 close of $20.43, after B. Riley $13→$32 (6/29) and UBS $22→$27 (7/14). The AI-power bid still works (7/30 Microsoft… FIG Figma, Inc. fresh LOW Design incumbent re-rated as an AI winner (BofA Buy, $30 PT, 7/7) rather than an AI casualty, yet the stock churns below its 100/200-day moving averages with heavy short interest into its first public earnings print on 8/5 — that print,… FLEX Flex Ltd. LOW AI-manufacturing re-acceleration: the 2026-07-09 Cerebras CS-3 production expansion is the first company-specific bid since the S&P-inclusion +6% pop round-tripped to ~$147, refreshing the data-center power/EMS narrative into the ~07-29 Q1… FLY Firefly Aerospace Inc. LOW Narrative and price have fully decoupled: FLY stacked a $144M CLPS award, a Moon BASE seat and a $13M Mars subcontract into a -47% drawdown, falling 9.6% on 7/16 on the awards headline itself. At $19.27 vs a $45 IPO price and 31% below the… FLYW Flywire Corporation Voting fresh LOW Flywire's execution re-rating requires Q3 growth confirmation and a recovery above the $19.54 market high. Growth above 16% excluding foreign-exchange effects and ancillary services, retention of full-year guidance, and a weekly close… FN Fabrinet fresh LOW Optical cluster re-accelerated in July (AAOI +390% YTD, LITE +138%, COHR +107%) while Fabrinet sits ~$478, +0.7% YTD and ~36% under its $748.89 high. Revenue compounds at +30% but the tape has decoupled from its own theme — a… FOSL Fossil Group, Inc. LOW Fossil Group's margin-turnaround rerating failed its published $5.00 weekly-close test with the 2026-09-11 close of $4.73. The operating recovery remains unconfirmed pending evidence for management's 2026-08-12 forecast of Q4 sales growth… FOUR Shift4 Payments, Inc. LOW Payments roll-up at ~$50, a hair above its $46.26 52-week low set on a 2026 guide-down. The Global Blue tax-free-shopping integration ("Shift4 One," launched 2026-07-14) is the transformation leg, but the 2026-07-30 Q2 print is the binary… FPS Forgent Power Solutions, Inc. fresh LOW Second secondary in five weeks — ~43.6M shares at $49 on July 2, now including company primary dilution — confirms the recurring-supply pattern and dragged the stock from its $65.56 June-4 ATH back to the offering line. The… FRD Friedman Industries Inc. LOW Tariff-driven HRC steel prices at multi-year highs powered record FY2026 (EPS $2.76, sales +46%); FRD hit an all-time-high close $37.42 on 2026-06-18 and was flagged overbought the same day. The narrative is maturing and priced near the… FSLY Fastly, Inc. LOW Fastly’s security-led recovery now has a Comcast deployment story; the 2026-09-22 Investor Day tests whether it gains financial support. The recovery case requires a weekly close above $27.69 with annual revenue guidance intact before a… FWRD Forward Air Corporation LOW Busted-merger workout losing its bid: the +48% June bounce to $14.87 (on a speculative Amazon-bolt-on thesis) has faded ~13% to ~$13, whole-company sale is now reported "unlikely," and the 2026-07-10 chairman exit forfeited… G Genpact Limited fresh LOW Agentic-operations pivot keeps compounding in the segment data — ATS +24.1% to $363M, FY guide lifted to at least 25% on 2026-08-06 — while the 73% legacy book grew 1.9% and caps consolidated growth near 7%. The 10-Q filed 2026-08-07… GCO Genesco Inc. fresh LOW The operating turnaround is real but priced, and its one asymmetric leg — the activist proxy fight — lost its teeth: ISS (2026-07-07) backed all nine board directors and urged holders to withhold from the two Radoff/Jumana nominees, so the… GDRX GoodRx Holdings, Inc. fresh LOW GoodRx's Pharma Direct and subscription pivot must restore total revenue growth. The next quarterly release confirms the case if growth returns and the $790–805 million annual outlook holds before a weekly close below $3.00 invalidates the… GEN Gen Digital Inc. fresh LOW Gen Digital’s security-funded financial-services pivot supports a recovery thesis, tested by Q2 revenue against August’s guidance. The price case succeeds with a weekly close above the September 18 adjusted high of $31.41 before a weekly… GENI Genius Sports Limited fresh LOW Sports-data toll-booth under the prediction-market boom, but the boom arrived and the toll didn't: Kalshi/Polymarket cleared $50B+ of World Cup volume (Coindesk, 2026-07-14) while GENI slid $6.43 → $6.30 and printed $5.98 intraday July 17.… GFI Gold Fields Ltd ADR fresh LOW Margin-to-cash story intact from H1 (2026-08-25: $2.225bn adjusted FCF, dividend +132%, realised $4,678/oz), but the macro leg inverted on 2026-09-04 when 162k August payrolls against ~53k expected pushed September hike odds to roughly 65%… GFS GlobalFoundries Inc. fresh LOW Photonics/CHIPS delivery kept accelerating — comms/data-center revenue +62% YoY in Q2 (2026-08-05), $300M Commerce LoI 2026-07-29 — while the multiple collapsed 39.2% from the $89.83 52wk high to $54.58 on 2026-08-14. What's on offer is a… GGAL Grupo Financiero Galicia S.A. fresh LOW Argentina disinflation is still working — June CPI printed 1.9% MoM on Jul 14, an improvement on May's 2.1% — but the ADR faded the good print, dropping ~7% on the week to ~$50 and losing both the $51.07 50-day and the $52.86 200-day.… GLUE Monte Rosa Therapeutics, Inc. fresh LOW ZEUS (ziltivekimab, MACE HR 0.99) failed on 2026-07-31 and took GLUE −27.16% to $16.52, its worst session on record, because the hsCRP-to-outcomes link under MRT-8102's ASCVD story is exactly what ZEUS could not demonstrate. Platform,… GOLF Acushnet Holdings Corp. fresh LOW Premium-golf consumable franchise (Titleist Pro V1) that ran to a $119.65 all-time high on a defensive-quality rotation, then bled ~11% of the mania premium back to the ~$104–105 June breakout shelf ($104.66 on 2026-07-24). The 2026-08-06… GOOG Alphabet Inc. LOW Alphabet’s Cloud backlog-conversion story needs sustained growth and margins without another capital-spending increase. The next quarterly report tests that case against the July results; a weekly close below $328 invalidates the… GRND Grindr Inc. fresh LOW Grindr’s premium-subscription pivot underpins a recovery thesis, but EDGE monetization remains unmeasured. A daily close above $17.94 by 2026-09-30 would complete the recovery case; a weekly close below $14.50 or expiry without that… GRPN Groupon, Inc. fresh LOW Groupon’s squeeze-revival case requires a weekly close above $22 and third-quarter billings growth of at least 4% before a weekly close below $18. The September 18, 2026 close of $19.08 leaves the price condition unmet, while the September… GSHD Goosehead Insurance, Inc. fresh LOW Goosehead Insurance’s recovery case requires renewed core-revenue growth and a weekly reclaim of $64 after the September 18 structural failure. Q3 core growth above 10% would confirm the operating leg; a weekly close below $54.28 would… GSM Ferroglobe PLC LOW US trade-remedy leg: the 2026-08-03 USITC affirmative vote forces AD/CVD orders on Australian and Norwegian silicon metal, on top of Angola/Laos orders live since 2026-03-17. Q2 (2026-08-04) delivered the sequential recovery — $13.1M adj… GTM ZoomInfo Technologies Inc LOW Legacy B2B data business trying to re-price as the data layer under AI go-to-market agents. The 2026-08-05 post-print gap is intact but unextended — $3.97 on 2026-08-21, RSI(14) cooled 76.9→58.9 — and the 2026-08-11 Microsoft Copilot MCP… GTN Gray Media, Inc. LOW Gray Media's political-advertising and consolidation story needs Q3 guidance delivery and a weekly recovery above $5.00. A weekly close below $4.50 invalidates the remaining repricing thesis; Q3 revenue below management's $935 million… GTX Garrett Motion Inc. LOW Turbo cash-cow re-rated (~8–9x → ~18x) on a datacenter/industrial oil-free cooling narrative; the parabolic Feb→June leg (~$20→$36) is spent, shares faded ~11% to the 50-day near $32.30, and the ~late-July Q2 print is the first chance to… GWRE Guidewire Software, Inc. fresh LOW Guidewire Software’s cloud-and-AI re-rating thesis failed its price test when the 2026-09-18 weekly close of $144.29 breached $155. Pohjola’s September 15 PricingCenter selection supports customer expansion, but a replacement recovery case… HCC Warrior Met Coal, Inc. LOW Warrior Met Coal’s Blue Creek ramp supports a cash-generation thesis, but price confirmation requires a weekly close above $110.18 before a weekly close below $95. Third-quarter results must sustain the sales outlook without further… HELE Helen of Troy Limited fresh LOW Helen of Troy's debt-reduction recovery failed its published price test at the 2026-09-18 close of $26.84. The expected 2026-10-08 results would test whether lower leverage and retained cash guidance support a renewed case, conditional on… HELP Cybin Inc. fresh LOW Post-dilution CNS microcap re-firing with the psychedelic cohort (ATAI, CMPS all moving 2026-07-16) after a June social-velocity blowoff and a 10.3M-share secondary at $4.85. Both covering shops cut targets in July while holding Buy. No… HIMS Hims & Hers Health, Inc. LOW GLP-1 reaccel gets marked to market on 2026-08-10: guide $680-700M (+25-28%) vs Q1's +4%, street at $698.9M. Since the last note the FTC/CA/UT sued (2026-07-29, N.D. Cal.), BofA cut $37 to $30, and Amazon ($50/mo Medicare GLP-1,… HL Hecla Mining Company LOW Hecla Mining Company's silver-margin story now hinges on recovering the 2026-09-03 close of $21.21. A weekly close above $21.21 completes the recovery case; a weekly close below $19 invalidates it. HMY Harmony Gold Mining Company Limited fresh LOW Harmony Gold’s cash-return thesis failed when the 2026-09-18 weekly close of $19.92 breached its published $20 threshold. The declared October dividend remains a catalyst, but it cannot reverse that recorded invalidation. HOV Hovnanian Enterprises, Inc. Class A LOW The housing-bill leg is spent — the Act auto-enacted 2026-07-11 and nothing dated has replaced it — yet HOV has re-rated to $137.78 (2026-08-07), 11.8% off the $156.16 high, on no company news. The confirmed 2026-08-20 Q3 print (quarter… HPP Hudson Pacific Properties, Inc. LOW Hudson Pacific Properties’ recovery case rests on leasing gains overcoming the cash restrictions disclosed on 2026-09-11. A weekly close above the August reference level of $14.50 would confirm the price recovery; a weekly close below $12… HRB H&R Block, Inc. fresh LOW H&R Block’s cash-return re-rating needs a recovery to its 2026-09-04 close of $49.06 with fiscal 2027 guidance intact before a weekly close below $44. The 2026-09-18 close of $44.25 leaves that recovery case under pressure. HROW Harrow, Inc. fresh LOW Show-me on an H2 ramp with nothing company-dated to resolve it before the ~November Q3 print: the reaffirmed $350–365M FY2026 guide needs the back half to roughly double H1's $114.9M against $292.4M loans payable net, and sell-side FY… HTLD Heartland Express, Inc. fresh LOW The margin-recovery leg printed on 2026-07-30 (operating ratio 91.0% vs 105.9%) and drew no lasting bid: price slid from $12.84 on 2026-08-21 to $12.44 on 2026-09-04, RSI 43.9, at the bottom of the August $12–$13 band, while freight… HURN Huron Consulting Group Inc. LOW AI-disruption discount still unwinding, but the bid has stopped widening: the 2026-08-28 close of $159.84 is below the 2026-08-21 close of $161.64, no analyst has moved a target since 2026-07-29, and Huron has published nothing since the… IART Integra LifeSciences Holdings Corporation LOW Med-device turnaround re-rating is now fully banked into Hold-grade targets: BMO initiated Market Perform $19 (Jul 9) and Citi raised to Neutral $19 (Jul 8), both landing on the tape (~$18.76). The distressed-to-fair leg is done; only… IBKR Interactive Brokers Group, Inc. fresh LOW Interactive Brokers' account-growth story supports a recovery case, but trading activity must rebound after August's sequential decline. A weekly close above the market's $98.10 high completes the price case; a weekly close below the… ICHR Ichor Holdings LOW Memory-capex WFE subsystem re-rating broke on the 2026-08-03 Q2 print: revenue $294.8M missed $300.2M consensus, the $78 June shelf failed, and the 2026-08-07 close was $68.32 against a $112.28 high. Q3 guidance still beats ($315–345M vs… IESC IES Holdings, Inc. LOW IES Holdings' data-center backlog supports a conditional price recovery after August's failed breakout. A weekly close above the $396.98 adjusted annual high completes the recovery case; a weekly close below $345 invalidates it. IHRT iHeartMedia, Inc. LOW M&A leg is dead — no SiriusXM headline since the 2026-05-29 NYT "stalled" report and the April spike fully round-tripped ($6.33 high → $3.86 on 2026-08-07, -39%). What is left is a binary: Q2 print 2026-08-10 after the close is the first… IKT Inhibikase Therapeutics, Inc. fresh LOW Inhibikase Therapeutics’ Phase 3 execution could restore its pulmonary arterial hypertension re-rating. A weekly close above the September 18, 2026 reference high of $2.52 would establish the price case; a weekly close below the July… ILMN Illumina, Inc. LOW Illumina’s NovaSeq X recovery has a September 21 index catalyst, but price confirmation remains absent. A weekly close above the $227.69 reference high and delivery against July’s third-quarter revenue outlook would validate the case; a… IMRX Immuneering Corporation fresh LOW Busted-catalyst pancreatic biotech: atebimetinib's 17.3-mo single-arm 1L OS is real, but the Phase 3 binary is mid-2028 and the tape keeps fading post-ASCO ($5.11→$4.32 in two weeks) even as targets climb to $18–$30. Cheap… IMVT Immunovant, Inc. fresh LOW Immunovant’s recovery case depends on IMVT-1402 clinical progress restoring the market’s $44.96 reference high by December 31, 2026. A weekly close below $35 invalidates the case; the September 18 three-month decline and undated clinical… INDI indie Semiconductor, Inc. LOW Automotive ADAS-silicon design-win story keeps improving on paper ($7.4B backlog, $25M radar order, ams OSRAM sensor buy) while the tape stays broken below the ~$4.00 50-day MA; TD Cowen's 2026-07-13 lift to a $4.50 Hold is a thaw, not a… INHD Inno Holdings Inc. fresh LOW Inno Holdings' remaining cash-backed recovery case requires a weekly close at or above the September 4 market close of $4.53 before a weekly close below $3.05. The September 18, 2026 close already breached the earlier $4.00 condition,… INOD Innodata Inc. fresh LOW AI training-data pure-play with a still-accelerating fundamental story (Q1 rev +54%, 40%+ FY26 guide reaffirmed 06-17) but a fully broken chart: ~-51% from the June $125.14 ATH to ~$61, with the CEO filing a fresh 200k-share sale on 07-16… INTA Intapp, Inc. LOW Intapp’s AI integrations support an existing-client expansion thesis; the next quarterly report tests whether bookings convert into revenue. Confirmation requires revenue above the $160.3 million quarterly guide and cloud ARR growth of at… IONQ IonQ, Inc. LOW IonQ's combined-company guidance restores a measurable revenue story; a weekly close above $44 would establish price repair. A weekly close below $36 first would invalidate that recovery case. IPAR Interparfums, Inc. fresh LOW Interparfums’ Cavalli renewal reinforces its long-license growth story, but earnings confirmation remains pending. The case plays out with a weekly close above the September 18 recorded high of $127.63 while annual guidance stays intact,… IPX IperionX Limited fresh LOW US critical-minerals sovereignty name whose funding overhang cleared the ugly way: a 2026-07-08 US$50M ADS raise priced at $21.98, ~22% below the ~$28 pre-deal level, resetting the stock to $22.94 near its $21.66 52-week low. Pre-revenue,… IQ iQIYI, Inc. fresh LOW Long-form streaming growth is broken in the reported numbers (Q1 2026 revenue -13% YoY, operating income to a RMB228.4m loss), so what is left is the micro-drama/overseas pivot — newly branded as Undercurrent Theater in early August 2026 —… IT Gartner, Inc. LOW Gartner’s recovery depends on subscription growth improving after the August earnings rebound weakened. Confirmation requires faster contract-value growth, maintained revenue guidance and a weekly close above the August 28 reference close… JACK Jack In The Box Inc. fresh LOW June's move was a float mechanic — Russell Microcap inclusion (effective 2026-06-30) into a 40%-short float drove $8.92 to $18.13, and it is unwinding ($14.98 on 2026-07-17, -7.76%). SSS is genuinely inflecting (-6.7% → -3.8%), but price… JBIO Jade Biosciences, Inc. fresh LOW Jade Biosciences' JADE101 dosing story supports a conditional recovery case, but patient efficacy remains unresolved. A weekly close above the lost July $21 shelf would establish price repair; a weekly close below the June offering… JBLU JetBlue Airways Corporation fresh LOW Fuel-reversion bull leg broke: Brent re-spiked to ~$86 (Jul 17) on renewed Mideast conflict, reversing the sub-$73 tailwind the whole trade needed. Raymond James (Jul 6) cut to Underperform flagging a Chapter 11 that wipes equity; $9.3B… JELD JELD-WEN Holding, Inc. fresh LOW JELD-WEN's post-2026-08-03 re-rating has stalled: the 2026-09-04 close of $2.30 is back below the 2026-08-28 close of $2.53, RSI(14) has cooled from 71.2 to 61.0, and no company disclosure has landed since the 2026-08-05 analyst updates.… JOBY Joby Aviation, Inc. fresh LOW eVTOL cert story still advancing (FAA TIA testing, 2026 Dubai target) but the trade rolled over: ~$8 testing support, down ~33% since June 1, recovery base gone, CFO sold ~half his stake June 8, consolidation coverage marks sentiment… JWEL Jowell Global Ltd. fresh LOW Low-float China e-commerce microcap that repriced +106% intraday on 2026-08-10 with no filing behind it; the leg being bought is float scarcity (2.38M shares out, $7.3M market cap) plus a 0.04x sales optic. Nothing on the calendar resolves… KALU Kaiser Aluminum Corporation fresh LOW Section 232 aluminum supply-shock (50% duty through 2027) plus a Q1 earnings inflection already repriced KALU ~+175% YoY to a $195 high; the move is maturing toward saturated with price at/above every published target. The estimated… KC Kingsoft Cloud Holdings Limited LOW China AI-compute capacity story is intact on fundamentals — AI gross billing +90% YoY and past half of public-cloud revenue in Q1 (reported 2026-05-27) — but the price leg broke: -32.3% from the $18.21 high with RSI(14) back at 70.0. The… KEEL Keel Infrastructure Corp. fresh LOW Former Bitfarms miner→AI/HPC-datacenter pivot has rolled over: June's push to ~$6.14 into Citizens' $10 initiation retraced to a ~$4.975 ref by 07-06, losing the $5.00 convert shelf and drifting toward the $4.00–4.20 base. Still zero… KGS Kodiak Gas Services, Inc. fresh LOW Legacy-pivot repricing has stalled into a four-week range: the 2026-09-04 close of $62.59 sits between the 2026-08-10 low of $59.72 and the 2026-08-14 close of $65.35, with no company press release since 2026-08-06 and no dated catalyst… KLAC KLA Corporation fresh LOW KLA Corporation’s inspection-demand recovery case requires September revenue of at least $4.0 billion and a weekly close above $210 by its earnings report. A weekly close below $175 breaks the case; the September 18, 2026 close was $176.99. KLC KinderCare Learning Companies, Inc. fresh LOW Distressed post-IPO childcare name has retraced ~180% off its $1.75 spring low to $4.93 as growth shifts to B2B/employer care and before-after-school (Champions +17% YoY), while the core ECE business still shrinks (−3% enrollment). The ~13… KMTS Kestra Medical Technologies, Ltd. LOW WCD share-capture story intact on fundamentals — FY26 revenue $95.1M (+59%), fiscal Q4 gross margin 54.8% — but the bid has thinned: the close was $25.64 on 2026-08-28, 9.6% under the $28.35 52-week high, with RSI(14) at 13.5 against 67.8… KNX Knight-Swift Transportation Holdings Inc. fresh LOW Beat-and-raise is filed (Q2 adj EPS $0.63; Q3 guided $0.71–$0.77) but the equity is flat since 2026-08-21 at $71.99 while the driver stalled rather than reaccelerated — all-mode tender rejections 13.57% on 2026-08-25 versus a July 4 peak… KOD Kodiak Sciences Inc fresh LOW Kodiak Sciences' repricing case rests on September DAYBREAK success and a weekly recovery above the former $36 shelf. Both investigational arms must meet their primary endpoints, while a weekly close below $32 invalidates the setup. KODK Eastman Kodak Company fresh LOW Eastman Kodak's materials pivot needs Q3 to repeat Q2's $105 million segment revenue and 26% consolidated gross margin before a weekly close below $9.20 breaks the recovery thesis. The September momentum improvement does not resolve… KOS Kosmos Energy Ltd. fresh LOW Jubilee ramping toward ~90,000 bopd gross (J76 online, J77/J50 imminent) with GTA LNG volumes climbing. Highest-beta E&P expression bounced ~15% off the $2.00 June low; re-accelerating but still a ~$2.30, 'CCC'-rated, most-levered… KRO Kronos Worldwide, Inc. fresh LOW Kronos Worldwide’s titanium-dioxide recovery needs higher third-quarter selling prices and continued segment profitability to validate August’s earnings rebound. The September 11 close of $8.14 has lost the earlier $8.20 shelf; a weekly… KRT Karat Packaging Inc. LOW Karat Packaging’s tariff-refund re-rating needs recurring sales and margin delivery to resume. Third-quarter results meeting the August 6 guidance and a weekly close above $49.80 would validate continuation; a weekly close below $40 would… KSS Kohls Corporation fresh LOW Squeeze leg has stalled: Morgan Stanley's 2026-07-06 Underweight/$15 reinit broke the one-way upgrade cluster and knocked the stock -5.9% on 07-08. Price ~$17.18 still holds above the 50- and 200-day, but with the sell-side now two-sided… KVYO Klaviyo, Inc. fresh LOW Klaviyo’s AI-agent expansion still needs attributable revenue, while the September 18 close invalidated its August recovery. A weekly recovery above $17.71 and agent revenue disclosure would be required to establish a new case. LAC Lithium Americas Corp. fresh LOW Lithium Americas’ Thacker Pass recovery thesis failed when the 2026-09-18 weekly close of $2.86 breached the published $3.00 shelf. A reclaim and the next construction update would support reassessment; JPMorgan’s September 9 endorsement… LAD Lithia Motors, Inc. LOW Lithia Motors’ finance-led re-rating requires dealership revenue to recover alongside lending income. The next quarterly results test that combination; a weekly close below $340 invalidates the price thesis. LAR Lithium Argentina AG fresh LOW Commodity transmission is now broken in both directions: the GFEX front carbonate quote came off to ~CNY 152,000/t on 2026-09-04 from CNY 156,140/t on 2026-08-22 while the shares went $6.83 to $6.79. The saturated lithium-recovery story… LBRX LB Pharmaceuticals Inc LOW LB Pharmaceuticals’ funded schizophrenia trial supports a recovery thesis, tested by a weekly close above $49.48 before a weekly close below $42.80. NOVA-2 results guided for the first half of 2027 settle the separate clinical question. LEGN Legend Biotech Corporation fresh LOW In-vivo CAR-T re-rate has matured into digestion: EHA (6/13) confirmed LB2501's 100% ORR and clean durability, but the 6/17 $226M raise at $29.35 capped the leg and JPM's 7/13 Neutral $35 reinstatement caps the Street. No fresh catalyst… LGIH LGI Homes, Inc. fresh LOW LGI Homes has a low-conviction recovery case toward its former $54 threshold after August closings grew 9.9% year over year. A weekly close above $54 completes this separate stabilization hypothesis; a daily close below the September 18… LGN Legence Corp. fresh LOW AI-datacenter MEP/HVAC pick-and-shovel story still improving on fundamentals (record $5.38B backlog, FY guide raised to $4.1–4.3B), but the tape has decoupled: ~33% off the $102 May close high, LGN sliced the $76 breakout shelf and rolled… LILAK Liberty Latin America Ltd. fresh LOW Post-catalyst drift: the $500M preferred special dividend and the June Malone/Nair insider cluster already drove a ~70% run off $4.76 to ~$8.30, and the tape has stalled at $7.33. Citi cut to Neutral 2026-07-10 with a $8 target already… LIND Lindblad Expeditions Holdings Inc. LOW Lindblad Expeditions’ occupancy-and-pricing rerating thesis failed when the 2026-09-11 weekly close of $25.67 breached its published $26.56 threshold. The August operating results support the underlying execution story, but they do not… LITE Lumentum Holdings Inc. LOW Two initiations in two sessions — Evercore ISI $1,100 on 08-31, Deutsche Bank $1,200 on 09-01 — and the tape closed 2026-09-02 at $870.58, still under the $885 weekly-close level and below the 08-31 close of $914.76. The $40 fiscal-2028… LOVE The Lovesac Company fresh LOW The 2026-08-27 notice made the binary real: Q2 FY27 lands before the open on 2026-09-10 against a company bar of $157–166M net sales and −$4M to +$2M adjusted EBITDA. Price closed $16.69 on 2026-09-04, under the 50-day at $16.95 and above… LQDA Liquidia Corporation fresh LOW Liquidia Corporation’s recovery case rests on YUTREPIA sales growth and a reclaim of the published $70 shelf. A weekly close above $70 plus next-quarter product sales above Q2 2026’s $170.4 million would confirm the case; a weekly close… LRMR Larimar Therapeutics, Inc. fresh LOW Single-asset FA regulatory binary sitting on the line that defines it: the week ending 2026-09-04 closed $3.83, 0.8% above the twice-tested $3.80 shelf, after five weeks with no company press release since the 2026-08-04 Q2 update. The… LTH Life Time Group Holdings, Inc. LOW Life Time Group Holdings’ premium-club re-rating needs recovery above the August placement price and retention of July’s raised growth outlook. A weekly close above $43.16 and unchanged guidance at the next results would satisfy the case;… LUNR Intuitive Machines, Inc. LOW The June 30 NASA Moon BASE award ($148.3M Nova-C) bought exactly one green session before the stock broke: seven straight down days into 2026-07-13 for -24.5%, -36.5% on the month, $13.80 on 2026-07-18 versus a $38.55 May high. A live… LZ LegalZoom.com, Inc. fresh LOW AI-reset narrative — a busted online legal-forms IPO repositioning as an AI-enabled SMB subscription platform (Anthropic partner, AI "digital mailroom") — drove a +29% 30-day rip into July. But it's stretched into the 2026-08-05 Q2 print,… M Macy's Inc. fresh LOW Morgan Stanley broke the all-Hold wall on 2026-07-06, resuming at Overweight with a $30 target and a $3 EPS-power call vs ~$2 consensus — the first real upgrade catalyst since the Q1 beat. But price faded the note ($23.99 → $22.64 by… MAMA Mama's Creations, Inc. fresh LOW The 2026-09-03 binary resolved for the fundamentals and against the tape: Q2 FY2027 revenue $54.58M (+55%) and EPS $0.06 both beat, gross margin recovered to 24.0% from 23.6%, and the shares still closed 2026-09-04 at $15.16, below the… MANH Manhattan Associates, Inc. LOW Cloud-conversion re-rating has printed a new 52-week high: the 2026-08-28 close of $223.28 is 0.2% under the $223.76 high, RSI(14) 79.7, with price 4.2% above the $213.90 aggregate analyst target. The only new input since the 2026-07-28… MASS 908 Devices Inc. LOW 908 Devices’ handheld-detection recovery depends on the $6 million ProtectIR order announced on 2026-08-11 validating its revenue outlook. A weekly close above the $11.10 high reported on 2026-09-11 would confirm price recovery; a weekly… MATV Mativ Holdings, Inc. LOW Mativ Holdings’ margin-and-debt repair thesis requires the next quarterly report to sustain a 14.1% adjusted EBITDA margin and reduce net debt below $908.2 million before a weekly close below $11.50 invalidates the price structure. MAX MediaAlpha, Inc. fresh LOW MediaAlpha’s insurance-advertising growth has not sustained its price structure: the $10.49 close on 2026-09-18 invalidated the published $12 weekly threshold. Final Q3 revenue below $355 million would also contradict management’s… MAZE Maze Therapeutics, Inc. fresh LOW APOL1 kidney proof-of-concept intact and funded into 2029, but the only news since the last note was a conference calendar: the 2026-09-02 release scheduled fireside chats on Sept 9, 10 and 15 and repeated the late-2026/early-2027 HORIZON… MCHP Microchip Technology Incorporated fresh LOW AI-data-center re-rating leg is unwinding — round-tripped from the $105.91 May ATH to the ~$84 50-day EMA under an unrebutted J Capital short thesis and a 2026-07-13 TD Cowen PT cut to $90; only the cyclical MCU/industrial recovery (~93%… MDB MongoDB, Inc. fresh LOW Atlas re-acceleration (+29.4% YoY, record $117M seq add; Q1 FY27, 2026-05-28) is intact, but the +18.5% post-print breakout fully round-tripped from $444.72 to a $294.10 close as the AI-software theme sold on margin-timing fear. Sell-side… MEDP Medpace Holdings, Inc. fresh LOW Bookings-inflection leg (Q2 awards $795.7M, +28.2% YoY, 1.13x book-to-bill, FY26 guide raised 2026-07-22) unchanged on fundamentals, but the tape has given back part of the August recovery — $600.65 on 08-28 to $591.29 on 09-04 — while the… MESO Mesoblast Limited fresh LOW Mesoblast’s Ryoncil-funded pipeline thesis faces a sales-growth test at the next quarterly report and weakening price support. A weekly close above the 2026-07-15 high of $18.07 would complete the recovery case; a weekly close below $15… MGM MGM RESORTS INTERNATIONAL fresh LOW Take-private process went live: WSJ reported substantive Diller talks 2026-07-10, MGM seated a special committee mid-July, and the board reportedly views $48.30 as too low — so the trade is now a bump handicap, not a growth story. At… MGNX MacroGenics, Inc. fresh LOW MacroGenics' MGC026 revaluation thesis turns on the 2026-10-23 cancer-data presentation. Cohort-level response and durability evidence followed by a weekly close above $4.86 would confirm the case; a weekly close below $3.90 invalidates it. MKSI MKS Inc. LOW Operating leg accelerating into a de-rating tape: Q2 (2026-08-05) beat at $1.248B revenue / $3.30 adj EPS, Q3 guide $1.310–1.390B tops the $1.243B Street, leverage down to 3.0x — and the stock still fell 4.49% on the print and sits 31.4%… MLKN MillerKnoll, Inc. fresh LOW MillerKnoll's recovery re-rating failed its published $22 weekly-close test on 2026-09-18. The 2026-09-22 results would support a replacement case only with recovering organic orders and backlog above the $679 million reported on… MMYT MakeMyTrip Limited fresh LOW MakeMyTrip's mid-year recovery bounce has stalled: after reclaiming the 200-day near $55, MMYT rolled back to ~$49, below both the 50- and 200-day, straight into an August 3 Q1 FY2027 print where consensus models EPS down ~76% YoY on ~137x… MNKD MannKind Corporation fresh LOW MannKind Corporation's Furoscix expansion tests its pivot beyond inhaled insulin. Q3 2026 Furoscix sales above Q2 2026's $22.2 million, with Tyvaso DPI royalties at least $32.4 million, would confirm the commercial leg before a weekly… MNTN MNTN, Inc. LOW MNTN, Inc.’s profitability re-rating depends on Q3 revenue exceeding the $86 million low end of August 4 guidance, positive net income and unchanged full-year guidance before a weekly close below $11.50 breaks the recovery case. The… MOD Modine Manufacturing Co LOW Modine Manufacturing's data-center cooling recovery requires better margins and a weekly reclaim of $210. The next quarterly report must improve on the 20.2% segment gross margin reported on 2026-07-29; a weekly close below $153… MOH Molina Healthcare, Inc. fresh LOW Molina Healthcare’s Medicaid recovery case needs a weekly close above $205 and October results preserving its July earnings floor. The 2026-09-18 close of $200.79 leaves price confirmation absent; a weekly close below $188 invalidates the… MOV Movado Group, Inc. fresh LOW Movado Group’s margin recovery remains unconfirmed by price; the re-rating case requires a weekly close above the $34.96 pre-results reference before a weekly close below $33 invalidates it. MPWR Monolithic Power Systems, Inc. fresh LOW Monolithic Power Systems’ AI power-management recovery case needs Q3 revenue above its $1,140 million guidance floor and a weekly reclaim of the $1,313.32 June pivot. A weekly close below $1,200 ends the price-recovery case. MRAM Everspin Technologies, Inc. fresh LOW Sympathy bid off the Micron-led memory supercycle and Russell 2000 inclusion floored the post-parabola markdown in the low-$20s, but the ~2026-07-28 Q2 print is now the binary: Everspin must show a non-casino datacenter/AI design win or… MRNA Moderna, Inc. fresh LOW Moderna’s cancer-treatment re-rating depends on full INTerpath-001 efficacy data and recovery above the market’s $174.38 event close. A weekly close below $130 invalidates the case; September investor appearances provide dated… MRVI Maravai LifeSciences Holdings, Inc. fresh LOW Maravai LifeSciences’ Moderna-linked supplier thesis failed its published $7.24 weekly-close test on 2026-09-18 at $6.97. Company-reported vaccine orders and a recovery above that threshold are needed to establish a new case. MSFT Microsoft Corporation LOW AI-capex derating still in control and now colliding with a hostile print tape: Alphabet lost ~$294B on 2026-07-24 punished purely for AI spend, Tesla/Intel/Google all sold post-earnings, and MSFT reports Q4 FY26 on 2026-07-29 AMC below… MTH Meritage Homes Corporation fresh LOW Housing-rebound-on-rate-cuts trade that carried MTH to a $85.38 52-week high has reversed: it lost the $75 June breakout shelf to $74.17 (-4.2% on 7/17) as mortgages held at 6.49% and Zelman capitulated to Neutral (7/7). Fundamentals still… MTRN Materion Corporation LOW Beryllium critical-materials scarcity narrative still building, but the parabola cracked: a new ATH of $298.76 in early July gave way to a 5.6% reversal on 2026-07-07 to $247.20, now ~$258 and still ~9% above KeyBanc's $237 top target. The… MTSI MACOM Technology Solutions Holdings, Inc. fresh LOW AI optical-interconnect arms-dealer with fundamentals still accelerating (FY26 DC growth guide >60%, Q3 guide $331-339M) but a July-broken chart: ~36% off the $418.90 high to ~$267 on the semi selloff, Russell Value index removal, and… MTUM LOW The AI-memory leg MTUM rotated into at the May reconstitution has rolled over: SOX -20%+ from its June peak, memory names in a bear market, and the fund closed $302.09 on 2026-07-17, below the $310 shelf that defined the… MYE Myers Industries, Inc. fresh LOW Legacy plastics maker re-rated ~2.4x on a "Focused Transformation" — MTS distribution arm in discontinued ops, capital concentrated behind Signature/MegaDeck composite matting (Infrastructure orders +130% YoY, Q1 adj EPS $0.44 vs $0.28).… NABL N-able, Inc. fresh LOW N-able's recovery case rests on repurchase support and recurring-revenue stabilization. The next quarterly report must show ARR above Q2's $544.5 million and revenue within the $134.5–135.5 million Q3 guidance before a weekly close below… NAT Nordic American Tanker fresh LOW Nordic American Tankers' freight-rate rally needs exceptional contracts to lift reported fleet earnings. Confirmation requires the next fleet-wide daily TCE to exceed Q2 2026's $63,000 per ship before a weekly close below the September 18… NBR Nabors Industries Ltd. fresh LOW Leveraged ~2x oil-beta proxy on the Hormuz war premium, +90% YTD near $100 but now rolling over: Susquehanna cut its target to $85 (2026-07-08) as the sell-side stops chasing, and the ~2026-07-23 Q2 print — the first to lap the premium —… NCLH Norwegian Cruise Line Holdings Ltd. fresh LOW Norwegian Cruise Line Holdings’ remaining case is activist-led recovery toward the $16 shelf lost on 2026-09-04. A weekly close above $16 would establish initial repair, while a weekly close below $14 would invalidate the case. NEO NeoGenomics, Inc. fresh LOW Oncology-dx turnaround accelerating — NGS +26%, PTEN IHC CDx (first FDA IHC companion dx in prostate, paired to AZ's TRUQAP) launched Jul 9, and TD Cowen $14→$19 / BofA $11→$16 on Jul 13 lifted consensus to ~$15.67, back above spot. But Q2… NESR National Energy Services Reunited Corp fresh LOW National Energy Services Reunited's oilfield expansion supports a recovery case: a weekly close above $36.31 before one below $32 would settle the price leg. The next quarterly release tests whether second-quarter revenue of $520.8 million… NEXA Nexa Resources S.A. fresh LOW Cyclical zinc-recovery confirmed and fully priced: Q1 EBITDA +126% YoY and Aripuanã's record 13kt ramp drove a run to the $16.89 high, but the equity now chops $12–13 while LME zinc printed a fresh 2026 high near US$3,622 — a bearish… NGNE Neurogene Inc. fresh LOW Neurogene's financed Rett gene-therapy thesis turns on Embolden meeting its clinical endpoint in the second half of 2027 before a weekly close below $30 breaks the market structure. NKE Nike, Inc. LOW NIKE's turnaround thesis requires the 2026-10-01 report to confirm gross-margin expansion and preserve its fiscal 2027 revenue outlook. A weekly close below $36 invalidates the recovery case; BMO's September Underperform initiation and the… NNE Nano Nuclear Energy Inc. LOW Nuclear-microreactor narrative has stopped converting news into demand: a Truist Hold/$22 initiation (7/14) and a Virginia consortium announcement (7/17) landed inside four sessions and NNE still printed a fresh 52-week low at $15.78… NOK Nokia Corporation fresh LOW AI-networking legacy re-rate extending on a harder catalyst leg — first commercial AI-RAN platform with Nvidia (07-15) plus Taiwan Mobile, Orange Belgium and NestAI defense wins. Theme accelerating, but the 2026-07-23 pre-open Q2 print is… NP Neptune Insurance Holdings Inc. fresh LOW The 2026-07-21 beat-and-raise has round-tripped: the 2026-08-14 weekly close of $31.71 is under the $32 post-print shelf, BMO cut to Market Perform on 2026-07-30, and the CFO sold 100,000 shares into $30.74–$32.12 on Aug 12–13. Operations… NRIX Nurix Therapeutics, Inc. fresh LOW Nurix Therapeutics' Roche-backed bexobrutideg story needs renewed clinical evidence after September's conference window. A weekly close above the $27.79 reference high would confirm the price leg; a weekly close below $24 would invalidate… NSIT Insight Enterprises, Inc. fresh LOW Genuine VAR margin-mix turnaround (Q1 GM +240bps, cloud GP +35%) but a derivative AI tag: hardware GP guided flat, sales +1%. Range-bound $102–123 since the early-June rejection; ~$110 already sits above the ~$103 street target with a… NUTX Nutex Health Inc. fresh LOW Re-rating leg has stalled: NUTX closed $162.98 on 2026-07-17 after five straight down days, ~20% off the $204.00 high, giving back the June breakout that B. Riley's 2026-06-26 Buy/$290 initiation topped out. A $55.0M true-up of 18,950… NVCR NovoCure Limited fresh LOW NovoCure Limited’s commercial-inflection thesis requires another revenue-guidance increase and positive adjusted EBITDA at the next quarterly report. A weekly close below $15.40 invalidates the July repricing; unchanged guidance would fail… NVEC NVE Corporation LOW NVE Corporation’s recovery case depends on repeating June’s product-sales jump and reclaiming the lost $105 shelf. The next quarterly report must show product sales at or above $10,734,735 alongside a weekly close above $105 before a… NWPX NWPX Infrastructure, Inc. fresh LOW Legacy steel-pipe maker re-rated into a water-infrastructure + precast roll-up on a record $373M WTS backlog, an ~83% Q1 beat, and the Permalok RBJ field win. Narrative intact but the setup is extended — last near $148, ~35% above the… NXPI NXP Semiconductors N.V. fresh LOW NXP Semiconductors' recovery case requires demand confirmation at October 27 earnings and a subsequent weekly close above UBS's published $270 target. A weekly close below $220 would invalidate the price structure first. ODFL Old Dominion Freight Line, Inc. fresh LOW Freight-cycle recovery in the top-margin LTL name is drawing a broadening upgrade cluster now printing above spot (Stifel $256 Jul 21, Truist $250 Jul 15, RJ $241 Jul 13), but growth is still rate and mix with tons/day negative. The… ODTX Odyssey Therapeutics, Inc. fresh LOW Odyssey Therapeutics' OD-001 re-rating depends on October expansion data sustaining its reported ulcerative-colitis efficacy. Confirmation requires comparable results retaining 27% remission and 61% response at UEG Week on October 17–20,… OEC Orion S.A. LOW Deep-cyclical carbon black where the 2024–25 tire-restock leg already failed (-32.5% from the $10.72 52-week high). What is left is a trough-and-deleverage read: Q2 2026 adj. EBITDA $58.2M (+26% sequential, -15% YoY), FY26 guide reaffirmed… OFIX Orthofix Medical Inc. LOW Orthofix Medical’s reimbursement-led recovery thesis failed when the 2026-09-11 weekly close of $8.93 breached $9.30. The next quarterly results must establish whether the operating recovery survives through confirmation of the revenue and… OII Oceaneering International Inc. fresh LOW Oceaneering International’s offshore earnings recovery needs third-quarter confirmation and a weekly close above $54.11 to validate renewed re-rating. A weekly close below $46 would invalidate the case; the September 8 sales range alone… OKLO Oklo Inc. LOW Three straight cohort-driven sessions carried OKLO from the 2026-07-29 close of $36.84 to $43.33 on 2026-08-04, with no Oklo release behind any of them. The 2026-08-07 Q2 call is the binary. OMDA Omada Health, Inc. fresh LOW Omada Health’s GLP-1 companion-care re-rating thesis failed when the September 18 weekly close of $20.43 breached its published $22 threshold. September 10’s long-term financial targets do not reverse that invalidation; a weekly close… ON ON Semiconductor Corporation fresh LOW The AI-power re-rate is unwinding, not consolidating: ON closed $87.37 on 7/17, below the 6/26 Synaptics deal-gap floor, with targets cut twice in three weeks (TD Cowen to $95 on 7/13, Mizuho to $125 on 7/1). Merger-arb supply plus a fixed… ONDS Ondas Inc. fresh LOW Ondas Inc.’s acquisition-led defense expansion needs Q3 revenue of $140–$155 million and a narrower adjusted EBITDA loss to validate it. A weekly close below $7.00 breaks the recovery case before that operating confirmation. OPEN Opendoor Technologies Inc LOW Early-July retail squeeze is broken: OPEN lost the $4.88 insider shelf and $4.50 base, fell ~12% to $3.88 on 2026-07-24 on a technical breakdown plus fresh housing weakness, into an Aug 4 Q2 print. A rolled-over meme trading into an… OPI Office Properties Income Trust Common shares of beneficial interest fresh LOW Office Properties Income Trust's recovery depends on refinancing completion and property sales validating post-reorganization equity. Expected financing settlement on 2026-09-24 supplies a dated test; the price case requires a weekly close… ORBS Eightco Holdings Inc. fresh LOW Eightco Holdings' recovery case rests on token assets and repurchases disclosed on 2026-09-17. Higher reported holdings and restored Nasdaq compliance would confirm it; a weekly close below $1.00 would invalidate it. ORIC Oric Pharmaceuticals, Inc. fresh LOW mCRPC PRC2 story de-risked as rinzimetostat enters registrational Phase 3 (Himalayas-1, 2026-07-14) with Bayer supplying NUBEQA and a J&J-backed enozertinib lung program behind it. But pivotal data is 2028+, so the only near-term mover is… OTEX Open Text Corporation LOW Open Text Corporation’s cash-return stabilization case depends on first-quarter revenue meeting its $1.220–1.250 billion plan with annual guidance intact. The 2026-09-11 close of $23.06 leaves the structure above its published shelf, but a… OTLY Oatly Group AB LOW Oatly’s guidance-led recovery failed its published $13.00 weekly price test at the $12.71 close on 2026-09-11. The next quarterly report must establish whether the operating recovery survives through confirmation of July’s revenue-growth… OUST Ouster, Inc. fresh LOW Squeeze leg broke: +43% in four sessions to a $63.79 high, then management priced 3.62M shares at $55.22 (~8% discount) and closed ~$191.9M net on 2026-07-06. Price round-tripped to $37.04, under the 20- and 50-day and under the $49… PATH UiPath, Inc. fresh LOW UiPath's agent-orchestration recovery case requires quantified commercial evidence at its 2026-09-22 Investor Day and a subsequent weekly close above $15. A weekly close below the September 11 reference close of $13.75 invalidates this new… PAY Paymentus Holdings, Inc. LOW Beaten-down bill-pay compounder: Q1 2026 revenue +30.2% YoY yet shares carved a $20.11 June 52-week low on margin-mix fear. Now ~40% off that low into a binary ~Aug-4 Q2 print — the read is a recovering base, not a chase. PAYC Paycom Software, Inc. fresh LOW Paycom Software's operating-leverage re-rating is testing its post-Q2 price shelf after the 2026-09-11 close of $218.91. A weekly close above the $240.52 reference high would establish renewed price strength; a weekly close below $214… PBI Pitney Bowes Inc. fresh LOW PBI broke the $17.62 shelf to a fresh 52-week high $18.62 (Jul 16) — the buyback/cost-cut re-rate is now extending, not consolidating. But revenue still shrinks ~3% YoY, consensus PT $16.43 sits below spot, and Q2 prints after close Jul… PBR PETROLEO BRASILEIRO S.A.-PETROBRAS ADS (REP 1 COMMON SHARE) LOW Petrobras’s oil-linked momentum thesis requires a daily close above the September 11 reference high of $21.38 before a daily close below $21.20. Reported production growth supports the operating story, but expanding market participation… PCOR Procore Technologies, Inc. fresh LOW Procore Technologies' jobsite-AI re-rating failed its $55.26 weekly price test at the September 18, 2026 close of $51.27, despite DroneDeploy's completion. A rebuilt case requires a weekly recovery above $55.26 and financial confirmation… PCT PureCycle Technologies, Inc. fresh LOW Post-dilution repair story: the June 10–15 raise (~$145M equity + $287.5M 4.75% converts, ~$11.08 conv) roughly halved the stock to ~$8 while the commercial ramp (Q1 record 8.4M-lb output, +161% revenue) held. The 2026-07-15 Mitsui/RM… PDFS PDF Solutions, Inc. fresh LOW Yield-analytics software re-rated on a real margin step — operating margin ~18%→25%, Platform revenue +36% YoY (Q1 reported 2026-05-07) — but the ~+280% run peaked at $69.05 on 2026-07-02 and flushed 11.5% intraday; the name is now… PESI Perma-Fix Environmental Services, Inc. fresh LOW Perma-Fix Environmental Services’ Hanford story needs Q3 revenue above $12.885 million and treatment revenue above $8.3 million to confirm waste-receipt conversion. A weekly close below $15 would invalidate the continuation thesis before… PI Impinj, Inc. fresh LOW Post-correction RAIN RFID recovery has extended to $138.37 (2026-07-17), holding the reclaimed $128 April gap-fill and pressing the $144.57 post-earnings high — but the entire near-term read is the 2026-07-29 Q2 print (guide $103–106M, EPS… PII Polaris Inc. fresh LOW Polaris’s earnings-recovery thesis failed its $62 weekly-close test at the 2026-09-18 close of $54.07. The next quarterly report tests whether operational earnings guidance survives, but cannot undo the price invalidation. PK Park Hotels & Resorts Inc. fresh LOW Park Hotels & Resorts’ earnings recovery needs a reclaim of the $15.32 August shelf and sustained guidance at the 2026-11-04 results. A weekly close below $14.60 or full-year adjusted FFO guidance below $1.90 per share invalidates the case. PKOH Park-Ohio Holdings Corp. fresh LOW Park-Ohio's infrastructure equipment story needs backlog growth beyond June's $252 million and retention of August's earnings guidance. The third-quarter report settles that case unless a weekly close below $45 invalidates the price… PL Planet Labs PBC LOW Planet Labs’ satellite-data growth supports a tentative recovery case after the September 3 earnings beat failed to preserve its July range. A weekly close above $19.16 before a weekly close below $16.45 would establish the defined… PLAY Dave & Buster's Entertainment, Inc. fresh LOW Dave & Buster's recovery case requires positive comparable sales and a weekly reclaim of the September 4 close of $8.72 before a weekly close below $6.73 invalidates it. The September 18, 2026 close already breached the prior thesis's… PLTK Playtika Holding Corp. fresh LOW Playtika Holding Corp.'s remaining recovery case depends on completed refinancing and preserved revenue guidance. Confirmation requires execution of the authorized bond financing and retention of the $2.75 billion full-year revenue floor… PLTR Palantir Technologies Inc. LOW Palantir Technologies' government and commercial AI expansion supports a recovery case, confirmed by a daily close above $180.18 before a weekly close below $165. September partnership headlines broaden distribution, but the September 11… PLUG Plug Power, Inc. fresh LOW The +475% hydrogen-comeback squeeze has broken: the $3.12 Q1 gap and the 50-day both failed, price is ~$2.17 (-20% in 30d), and Susquehanna cut its target $3.75 → $2.50 on 2026-07-10. The June 30 NY Gateway close resolved as a restructure… POWI Power Integrations, Inc. fresh LOW The 800VDC AI-power re-rate has cracked. POWI lost the $74–78 May breakout shelf in a -20% week to $70.45 (2026-07-17) and now sits below the $76.20 average target for the first time since spring. The GaN cohort broke with it — NVTS is… POWL Powell Industries, Inc. LOW Record orders $934M and a 3.0x book-to-bill lifted backlog to $2.4B (+69% YoY) at the 2026-08-03 print, yet shares fell 13.4% the next pre-market on a second straight EPS/revenue miss and closed 2026-08-14 at $213.48, -33.7% off the high.… PPTA Perpetua Resources Corp. fresh LOW Perpetua Resources’ domestic-antimony financing thesis requires definitive loan documentation and a final construction decision by 2026-12-31. The case fails first if a weekly close below $21 breaches the retained market boundary. PRGO PERRIGO COMPANY PLC fresh LOW Perrigo’s turnaround rests on asset sales reducing debt while core earnings guidance survives. A completed strategic transaction and subsequent results would confirm the case; a weekly close below $13.00 would invalidate its… PRLD Prelude Therapeutics Incorporated fresh LOW Prelude Therapeutics remains an Incyte option-exercise story: the $100 million fee would resolve the case positively if exercise precedes a weekly close below $4.75. September trial clearance adds pipeline progress, but the… PSQL Pasqal Holding SA fresh LOW Pasqal's funded quantum-commercialisation story faces its first scheduled public-results test on 2026-09-24. A subsequent weekly close above the $10.00 merger reference would confirm the recovery case; a weekly close below $7.00 would… PTRN Pattern Group Inc. Series A fresh LOW Pattern Group's ecommerce growth story needs Q3 delivery and a price recovery after the September conference window elapsed. A weekly close above the August reference of $23.16 would confirm recovery before a weekly close below $19… PVH PVH Corp. fresh LOW PVH Corp.’s legacy-brand reset needs earnings delivery and a recovery of the $75 shelf. The case is confirmed if Q3 results preserve the $11.80–$12.10 fiscal 2026 adjusted EPS outlook and the shares close a week above $75 before a weekly… QBTS D-Wave Quantum Inc. LOW D-Wave Quantum’s definitive federal award supports a recovery story, but Q3 recognition of its booked $20 million system sale must establish commercial conversion. The case fails on a weekly close below $16.18 or deferral of that sale… QDEL QuidelOrtho Corporation fresh LOW QuidelOrtho’s recovery case requires a signed point-of-care divestiture and a weekly reclaim of $13.75 before a weekly close below $10.62. The earlier deal-rumor thesis had already breached its published price condition by September 18,… QLYS Qualys, Inc. fresh LOW Qualys’ post-earnings recovery case requires a weekly close above the market’s August reference of $187.05 before a weekly close below $170 breaks it. The 2026-08-04 guidance increase supports the operating story, but Q3 revenue at or… QNST QuinStreet, Inc. fresh LOW QuinStreet's carrier-advertising recovery must translate into September-quarter guidance delivery and a price recovery before a weekly close below $17. Northland's 2026-09-17 target increase renews analyst support, but the 2026-09-18 close… QTWO Q2 Holdings Inc LOW Q2 Holdings’ margin-led recovery needs price confirmation after the September 11 close fell below its prior consolidation. A weekly close above $66 would confirm the price case before a weekly close below $58 invalidates it; the next… QUBT Quantum Computing Inc. LOW Quantum Computing Inc.’s commercialization story supports a tentative recovery case: a weekly close above the July 2026 shelf of $8.22 would resolve it before a weekly close below $7.30 invalidates it. The September 11 close of $7.99… QUIK QuickLogic Corporation fresh LOW The eFPGA/defense royalty squeeze has fully unwound: QUIK is ~$13, roughly 47% below the $24.33 June high, and the $18 shelf broke exactly as the Russell inclusion passed. July's post-quantum IP announcement drew no bid — good news into no… QURE uniQure N.V. fresh LOW FDA's 2026-06-17 reversal put AMT-130 on an accelerated-approval path with a Q3 2026 BLA — the narrative is genuinely repaired, but the move is spent: $40.25 (7/17) sits below the $45.50 June offering price with the CEO selling into it on… RARE Ultragenyx Pharmaceutical Inc. fresh LOW The +50% June reset rally round-tripped from ~$33.46 to $28.62 (2026-07-21), parking price back on the breakout shelf ahead of two binary FDA decisions: DTX401 (GSD Ia) PDUFA Aug 23 and UX111 (Sanfilippo A) PDUFA Sep 19. The July 30 Q2… RBLX Roblox Corporation fresh LOW Broken growth compounder: the age-verification rollout throttled DAUs and forced FY26 bookings guidance down to +8-12%; stock is -66% from its $150 high and below the 200-day. The 2026-07-30 Q2 print is the binary — it needs a DAU… RCKT Rocket Pharmaceuticals, Inc. fresh LOW Rocket Pharmaceuticals’ Danon recovery case requires clinical progress at the 2026-10-06 webinar and a weekly recovery above $3.86 before a weekly close below $3.20. The September 15 FDA-alignment announcement narrows regulatory… RDW Redwire Corporation LOW Post-SpaceX-IPO deflation broke RDW to a 2026-07-18 low near $8.51 (~67% off the 5/28 record). A relief bounce on Huntsville/Indiana facility news and $41.5M of H1 Stalker drone orders keeps running into a ~$850M dilution ceiling: the… REAL The RealReal, Inc. fresh LOW The RealReal’s luxury-resale growth supports a recovery hypothesis, but price confirmation is absent. A weekly close above $10.00 and third-quarter delivery against August 6 guidance would establish the case; a weekly close below $8.02… REAX The Real Brokerage, Inc. fresh LOW The binary resolved — the RE/MAX combination closed 2026-08-24 — and the deal move unwound with it: RSI(14) went from 88.0 on 2026-08-21 to 38.0 at the 2026-09-04 close of $18.67, under the mechanically restated $19.50 July shelf. What… RFAI RF Acquisition Corp II fresh LOW RF Acquisition Corp II's remaining story is a redemption-driven squeeze. A daily close at or above the 2026-08-21 closing high of $58 satisfies the prospective recovery case; a daily close below $35 or merger completion ends the pre-close… RGTI Rigetti Computing, Inc. LOW Quantum pure-play basket is in outright hype-cycle deflation: RGTI ~$14.19 (2026-07-17), -27% MoM, and the $14 shelf that held the May CHIPS-stake gap and the June executive-order pop has broken. Inverse quantum ETFs printing +108% and the… RH fresh LOW Squeeze leg now ratified by the sell side — TD Cowen $220 (2026-08-08) and Wells Fargo $225 (2026-08-11) against B of A's reinstated Underperform $156 (2026-08-03) — and it resolves into the 2026-09-10 Q2 print with ~56.7% of float still… RIVN Rivian Automotive, Inc. LOW Rivian Automotive’s recovery depends on its R2 second shift starting by September 30 and October deliveries exceeding Q2’s 12,194 vehicles while annual guidance remains 65,000–70,000. A weekly close below $12.90 invalidates the recovery… RLAY Relay Therapeutics, Inc. fresh LOW Relay Therapeutics' zovegalisib recovery case requires quantified Phase 3 enrollment progress by year-end 2026 and a weekly close above $20.75. A weekly close below $17.50 invalidates the case; the September 18 close of $18.84 has not… RLMD Relmada Therapeutics, Inc. fresh LOW Relmada Therapeutics’ NDV-01 re-rating thesis was invalidated by the $4.12 weekly close on 2026-09-18, below its published $4.25 shelf. A recovery above the March financing level and an announced IND submission would provide evidence for a… RMBS Rambus Inc. fresh LOW Memory theme is ripping — Micron +68% YTD with HBM sold out through 2027 — but Rambus has decoupled, down ~42% from its 2026-06-03 high of $174.10 to $101.44 while the cycle proxy sits near records. Interface content is a DIMM-unit story,… RPAY Repay Holdings Corporation fresh LOW The Visa-headline pop has round-tripped — $4.01 on 2026-08-21 back to $3.88 on 2026-09-04 — while the deal file stayed silent: the only company items since are an 2026-08-26 NxtEdge AP partnership and a 2026-09-03 IR hire, leaving… RZLT Rezolute, Inc. fresh LOW The August screener bid fully round-tripped: $5.09 on 2026-08-21 to $4.58 on 2026-09-04, back under the $4.60/$4.61 summer shelf, with no clinical news since 2026-06-17. The registrational upLIFT topline is still guided only to "2H-2026"… SABR Sabre Corporation fresh LOW June's +20% deleveraging bounce has fully round-tripped: $1.99 (6/26) back to $1.73 (7/17), now under the 50-day near $1.79 after failing exactly at the $1.99 consensus PT. Balance sheet is fixed, narrative is not accelerating, and a… SAH Sonic Automotive, Inc. LOW GPU-normalization narrative broke at the 2026-07-30 print: revenue and adjusted EPS beat consensus, but adjusted EPS fell 17% YoY, franchised segment income −23%, and EchoPark FY26 GPU guidance was cut ~$300 at the midpoint. Shares… SAIL SailPoint, Inc. fresh LOW Agentic-identity story intact and the post-earnings flush is basing: SAIL clawed from a $13.33 low (6/22) back to $15.68 (7/17), a higher low off the $10.30 bottom. Growth decelerated (ARR +26% vs +30%) and guidance was only affirmed, so… SANA Sana Biotechnology, Inc. LOW Type-1-diabetes functional-cure narrative: UP421's no-immunosuppression islet transplant is still producing insulin at 14 months (n=1), de-risking SC451's IND guided "as early as 2026." Rare-disease cell therapy is accelerating, but the… SANM Sanmina Corporation fresh LOW The prior break level gave way: the 2026-08-21 weekly close at $188.89 retraced the entire June re-rate. FQ3 on 2026-07-27 beat and raised — $3.46B revenue, +69.7% YoY, FY26 EPS guide lifted to $11.90–12.20 — and the tape answered with a… SAP SAP SE LOW SAP SE’s cloud-and-AI recovery thesis requires a weekly close at or above its 2026-08-28 reference close of $221.54 before a weekly close below $200 invalidates it. The 2026-09-11 close of $206.36 has lost the August shelf, while the… SATL Satellogic Inc. LOW The mania leg broke in July — the $6.33 shelf and the $4.97 range low both went — and the 2026-08-05 Q2 print handed the name a different story: revenue $15.9M (+259% YoY) vs $9.6M consensus, plus the first positive operating income and… SBSW Sibanye-Stillwater fresh LOW Sibanye-Stillwater's lower debt supports a metals-led recovery toward RBC's September 16 target of $15, conditional on no weekly close below $11.50. The September 18 palladium quote of $1,283 per ounce weakens the strike-premium argument. SEER Seer, Inc. fresh LOW The take-private ladder has stalled into a stand-off: the $2.55 Radoff-JEC bid lapsed unanswered on 2026-08-10, and the group's 2026-08-13 release demanding the board disclose an evaluation timeline has drawn no company reply through the… SFIX Stitch Fix, Inc. LOW Stitch Fix’s turnaround needs renewed customer growth at the 2026-09-23 results and a weekly reclaim of $3.50. A weekly close below $2.95 ends the revival case, while revenue below the June guidance floor would contradict its operating… SHOO Steven Madden, Ltd. fresh LOW Tariff-recovery leg has stalled into a $39.71–$47.11 range with insiders selling every rally and zero buys; the whole story now hinges on the confirmed 2026-07-30 Q2 print. Consensus targets sit at or below spot ($43.75, 07-16), adjusted… SIDU Sidus Space, Inc. LOW Sidus Space’s cash-and-launch recovery thesis failed when the 2026-09-11 close of $2.00 breached its $2.15 weekly threshold. Successful orbital operation and subsequent revenue growth remain the unresolved commercial tests. SITM SiTime Corporation fresh LOW MEMS-timing picks-and-shovels story is fundamentally intact — Q1 datacenter revenue +158% YoY to 67% of sales, Renesas timing deal closed July 1 — but the momentum leg has broken: ~$550 on July 18 is ~39% off the May 11 all-time-high close… SKM SK Telecom Co., Ltd. fresh LOW SK Telecom’s equity-funded AI data-center expansion supports a recovery case, but the September 18 close shows weakening price confirmation. A weekly close above the August reference of $40.29 would establish recovery; a weekly close below… SKWD Skyward Specialty Insurance Group, Inc. LOW Skyward Specialty Insurance Group’s niche underwriting and Apollo fee income underpin an earnings-resilience thesis in softer insurance markets. Confirmation requires Q3 maintenance of the $4.80–$5.00 annual operating EPS guide and a… SLDB Solid Biosciences Inc. LOW Solid Biosciences’ SGT-003 thesis depends on functional Duchenne data supporting an accelerated-approval pathway. Favorable disclosed FDA feedback would validate the case; an adverse regulatory outcome or a weekly close below $8.00 would… SLN Silence Therapeutics Plc LOW Silence Therapeutics’ post-readout continuation thesis was invalidated by the 2026-09-11 weekly close of $13.02 below $13.50. Divesiran’s August clinical result remains relevant, but a renewed case requires price recovery and a disclosed… SLS SELLAS Life Sciences Group, Inc. fresh LOW Borrowed sector re-rate has cooled: SLS closed $13.86 on 2026-09-04, 10.3% under the 2026-08-21 high of $15.46, RSI back to 54.1, while REGAL's last published count is still 78 of 80 from 2026-05-11 and BMF Capital's 2026-08-31 short… SMR NuScale Power Corporation LOW NuScale Power’s remaining case is a binding TVA power contract by end-2026 before a daily close below $7.96. The August-range recovery already failed when the shares closed at $8.61 on 2026-09-11, below the published $8.64 boundary. SMWB Similarweb Ltd. fresh LOW Similarweb’s AI data-licensing pivot needs Q3 revenue conversion to validate its repricing. Confirmation requires revenue within the $80.5–82.5 million guidance issued on 2026-08-12 and an AI-related revenue share above Q2’s 13%, before a… SNDR Schneider National, Inc. LOW Schneider National's contract-rate recovery needs the next report to sustain its improved Truckload margin and raised earnings outlook. The case is confirmed if margin matches the second quarter's 8.2% and the $0.90–$1.10 annual adjusted… SNEX StoneX Group Inc. fresh LOW StoneX Group's recovery case rests on revenue stabilization and a return above its September 4 reference close. Fiscal Q4 net operating revenue of at least $719.7 million and a weekly close above $69.46 would confirm it; a weekly close… SPIR Spire Global, Inc. LOW Spire Global’s government weather-data recovery thesis failed its $13 weekly-close condition at the $11.42 close on 2026-09-11. The September 18 delivery milestone tests execution, but cannot reverse that recorded failure. SPRB Spruce Biosciences, Inc. fresh LOW Spruce Biosciences’ Q4 2026 filing story depends on submitting its tralesinidase alfa application before a weekly close below $50. Management reiterated the window on 2026-09-15; submission by 2026-12-31 settles this filing case, while a… SPRY ARS Pharmaceuticals, Inc. LOW Single-product epinephrine name whose one catalyst — a July no-prior-auth formulary add for neffy — came and went unpaid; the stock has since broken its old $6.66 52-week low to fresh lows near $6. The neffy ramp is real but the access… SRAD Sportradar Group AG LOW Scope expanded, revenue did not: the 2026-08-27 Polymarket deal widened to 20+ leagues and ~300,000 matches a year, and the 2026-08-26 Euroleague renewal runs to 2031, yet the 2026-08-28 close of $12.94 sits below the $13.82 of two weeks… STAA STAAR Surgical Company fresh LOW The re-rating leg failed and has not been re-bid: after the 2026-08-21 weekly close at $23.14 broke the $23.50 shelf, ten sessions produced only $23.47 on 2026-09-04 and a 2026-09-02 CTO appointment the tape ignored. What is left is a… STM STMicroelectronics N.V. fresh LOW The June AI-data-center re-rating has failed its retest: $62.06 on 2026-07-17 is -22% from the 2026-06-22 high of $79.82 and back under the early-June breakout base, with a $1.5B convertible overhang and a 7% selloff that ignored a BofA… STRO Sutro Biopharma, Inc. fresh LOW Single-asset binary now inside its own catalyst window: the STRO-004 (DAR8 Tissue Factor exatecan ADC) Phase 1 readout was guided "mid-2026" and that window is expiring undated. Price has gone flat at ~$29.7 for four weeks after the June… STTK Shattuck Labs, Inc. fresh LOW Shattuck Labs' receptor-blocking antibody story has advanced to an open Crohn's trial, according to management on September 8. The near-term recovery case requires a weekly close above September 4's $6.79 reference close before a weekly… STUB StubHub Holdings, Inc. LOW June's busted-IPO recovery leg has fully reversed. D.C.'s RESALE Act (10% resale-markup cap, effective 2027-01-01) plus a Texas AG probe into undelivered World Cup tickets broke the experience-economy narrative; at ~$8.60 STUB trades below… SUPV Grupo Supervielle S.A. LOW Grupo Supervielle’s recovery thesis needs disinflation to reach credit growth and earnings. The next quarterly report tests for sequential loan growth and a nonperforming-loan ratio below 5.5%, while a weekly close below $7.50 invalidates… SVV Savers Value Village, Inc. LOW Busted-IPO thrift retailer's June recovery has stalled and rolled back toward its ~$9 base as the June 27 Russell-deletion passive-bid loss bites; the July 30 Q2 print is now an imminent, FX-exposed binary rather than a five-weeks-away… SWVL Swvl Holdings Corp Class A fresh LOW Swvl Holdings' financing-led re-rating still needs operating confirmation after its September 8 bank-facility expansion. A weekly close above the reported $7.94 52-week high would complete the continuation case; a weekly close below the… SXC Suncoke Energy Inc fresh LOW Coal-policy sympathy trade is fully dead: SXC has gone nowhere for three weeks, $8.39 on 2026-06-27 to $8.37 on 2026-07-17, pinned to the $8 shelf with no narrative velocity. The only live variable is the Q2 print, pulled forward to… SYNA Synaptics Incorporated fresh LOW Synaptics' fixed-ratio onsemi merger remains the central thesis; completion on announced terms before a weekly close below $90 would validate it. The September 15 annual proxy does not establish a merger-vote date. TAL TAL Education Group fresh LOW Legacy-pivot re-rating still intact on fundamentals — Q1 FY2027 revenue +31.9% to $758.4M with selling and marketing down 5% — but the post-print impulse has largely round-tripped: $12.16 on 2026-08-11 to $11.32 on 2026-08-21, RSI 37.2,… TASK TaskUs, Inc. LOW Mix-shift re-rating: AI Services hit $66.1M (+25.8%) in Q2 CY2026 on 2026-08-05 — seventh straight quarter above 25% — and is guided above 30% YoY in Q4 on AV/robotics work, against a 25%-of-revenue Trust & Safety book the market assumes… TBI Trueblue, Inc. LOW Deep-cyclical industrial staffer re-rated +140% off the $3.18 low on a staffing-demand recovery and a data-center/energy labor boom lifting PeopleReady +19% YoY. Still loss-making (Q1 net -$19.8M), margins compressed, and the… TDOC Teladoc Health, Inc. fresh LOW Teladoc Health’s cash-flow support case depends on BetterHelp stabilising before a weekly close below $6.00. The next quarterly report must meet the Q3 revenue floor of $569 million, hold average paying users at least at Q2’s 0.346 million… TDUP ThredUp Inc. LOW ThredUp's remaining case is a price recovery as buyer growth survives the August guidance reset. A weekly close above the $3.07 reference close of 2026-08-14 would satisfy that case; a weekly close below $2.50 invalidates it. TEN Tsakos Energy Navigation Ltd. fresh LOW Tsakos Energy Navigation’s tanker earnings and fleet renewal support a continuation thesis. A weekly close above $52.81 before a weekly close below $52.09 would confirm the next price leg. TENB Tenable Holdings, Inc. fresh LOW The S&P SmallCap 600 bid expired on schedule — after the ~12% move on 2026-08-27 and the $37.67 close on 2026-08-28, the 2026-09-04 close of $34.25 has handed most of the index gap back, and the 2026-09-03 OpenAI CyberAgents announcement… TENX Tenax Therapeutics, Inc. LOW Tenax Therapeutics’ recovery case depends on FDA acceptance of an enriched LEVEL-2 design after the failed trial’s subgroup signal. An agreed protocol would substantiate the case; a weekly close below $1.70 would invalidate its market… TER Teradyne, Inc. fresh LOW Parabolic AI-test leg broke hard: $483.84 closing ATH (2026-06-30) to $322.36 (2026-07-17), −33% in twelve sessions on a memory-glut scare, with the whole $446–$550 analyst band now stranded above spot. Company guided Q2 revenue DOWN… TGTX TG Therapeutics, Inc. LOW The catalyst leg is spent; what is left is whether the $46–48 shelf holds through a two-month news vacuum into year-end subcutaneous Phase 3 topline. TH Target Hospitality Corp. fresh LOW The AI-datacenter-landlord re-rate has stalled: TH peaked at $20.85 and has given back ~21% to $16.36 (2026-07-17) as TDR Capital affiliates distribute shares in-kind to partners, losing the $17 secondary clearing shelf while Oppenheimer… THC Tenet Healthcare Corporation New LOW Tenet Healthcare’s hospital-margin re-rating needs a weekly close above the August 21 high of $280.77 before a weekly close below $262 breaks the extension. The next results test whether the 18.0% hospital margin and annual earnings… TIC TIC Solutions, Inc fresh LOW Post-merger re-rate: engineering/geospatial backlog hit a record $1.18B (+20% YoY) on 2026-08-06 while legacy inspection fell ~5.5% combined, and UBS's 2026-08-11 upgrade (Buy, PT $12.50 from $11.00) prices an inflection that Q2's +2.5%… TLN Talen Energy Corporation LOW Contracted-floor re-rating has stopped paying: the 2026-08-05 Q2 raised FY26 Adj EBITDA guidance to $2,025–2,225M and PJM's 2028/29 auction cleared >10 GW at the $325/MW-day cap, yet the stock closed $347.71 on 2026-08-07, 22% below the… TLRY Tilray Brands, Inc. fresh LOW Reform binary spent without resolving: the DEA hearing closed 2026-07-15 with only a 2026-08-17 briefing deadline and no ALJ timeline, so Schedule III is now an open-ended administrative process. TLRY printed a fresh 52-week low of $4.20… TMC TMC the metals company Inc. fresh LOW The deep-sea-mining reshoring leg is broken: TMC has cut through the $3.93 prior 52-week low to a fresh $3.57 low near $3.74, roughly -67% from the $11.35 high, with no bid and no near-term catalyst. The decisive NOAA license decision is… TNDM Tandem Diabetes Care, Inc. LOW Beaten-down insulin-pump turnaround; the whole re-rate hinges on the tubeless Mobi ("Toby") 510(k) — planned for a Q2 filing but still unconfirmed after the quarter closed 2026-06-30 — plus margins scaling toward a ~60% Q4 exit. Shares… TNXP Tonix Pharmaceuticals Holding Corp. fresh LOW Tonix Pharmaceuticals’ Tonmya launch thesis requires Q3 sales and prescriptions to exceed Q2’s approximately $11.0 million and 12,592 prescriptions before a weekly close below $10.50. The 2026-09-18 close of $10.87 leaves weak price… TORO Toro Corp. fresh LOW Panagiotidis shipping shell (NOT lawnmower TTC) ran 1.93→8.50 on a sub-NAV/special-dividend story that is now fully paid out and closed. Six weeks of dead tape since the 2026-06-05 payout ($3.8M cash + 5,707,246 NEW shares); on a true… TRIP TripAdvisor, Inc. LOW Tripadvisor's residual-value case rests on TheFork proceeds and Experiences growth supporting a weekly recovery above $10. A weekly close below $9 invalidates the price case; failure to close TheFork by December 31, 2026 defeats the… TSAT Telesat Corporation Class A Common Shares and Class B Variable Voting Shares LOW Legacy GEO operator re-rating on a funded LEO pivot: 2026-08-04 C$2.3B, 15-year Canadian Arctic Mil-Ka contract expands Lightspeed 156→225 satellites and lifts the 2032 revenue target to US$4.9B from US$3.2B. Price closed at the 52-week… TSHA Taysha Gene Therapies, Inc. fresh LOW De-risking is behind the stock and the calendar in front of it is empty: after the clean 2026-06-22 data and the $6.00 June raise, no company-dated event lands before the ~November Q3 update, and the tape has drifted to a $5.60 close on… TSLA Tesla, Inc. LOW Tesla’s autonomy thesis requires Cybercab deployment to become a measurable business, confirmed by operating fleet and ride-pricing disclosures plus a daily close above $376.37. A daily close below $357 invalidates that case; the estimated… UCTT Ultra Clean Holdings, Inc. fresh LOW WFE upcycle intact fundamentally but the tape broke: -35% from the $142.59 all-time close (2026-06-30) back under the ~$95 breakout shelf on sector-wide selling with no company news. Failed breakout, no support to $80.55, binary Q2 print… UFPT UFP Technologies, Inc. fresh LOW UFP Technologies' medical-outsourcing recovery case requires a weekly reclaim of $300 before a weekly close below $273. The prior case failed at the 2026-09-18 close, while CI Medical's acquisition release provides no financial… UHAL U-Haul Holding Company LOW U-Haul Holding Company's storage-led re-rating failed when the 2026-09-11 close of $64.05 breached its published $68 weekly threshold. A recovery case requires a weekly close above the former $68.25 July shelf and improving storage… UI Ubiquiti Inc. fresh LOW Broken parabola gone flat: six weeks of $530–$570 chop after the May 8 print (GM 47.0%, rev +18.7%, but EPS $3.88 vs ~$4.42 whisper) with zero scheduled catalyst until the Q4 FY26 report on 2026-08-21. Fundamentals intact, tape dead,… UNH Unitedhealth Group Incorporated fresh LOW UnitedHealth Group's margin repair has yet to earn a market re-rating; the 2026-10-13 results test its $19.50–$20.00 full-year adjusted earnings-per-share outlook. A weekly close below $375 invalidates the price case. UNIT Uniti Group Inc. fresh LOW Hyperscaler dark-fiber demand turned the post-Windstream deleveraging grind into a growth story (~$1.5B disclosed funnel, $68.7M of Q1 IRU revenue from one hyperscaler), but the June re-rate to ~$11 has stalled in a three-week range above… URGN UroGen Pharma Ltd. LOW UroGen Pharma’s ZUSDURI launch-growth thesis requires third-quarter revenue above the second quarter’s $50.4 million before a weekly close below $40 invalidates the structure. The confirmed 2026-09-15 conference adds management exposure,… UUUU Energy Fuels Inc. LOW Two sell-side target raises in consecutive sessions — HC Wainwright's $29.25 on 2026-09-01 and Cantor Fitzgerald's $33 reiteration on 2026-09-02 — moved the shares less than 1%, to a $14.29 close 48.4% under the 52-week high. With rare… VAC Marriott Vacations Worldwide Corporation fresh LOW Marriott Vacations Worldwide’s earnings-led re-rating failed its $106 weekly price test at the 2026-09-11 close of $103.59. The next quarterly results must establish whether the operating recovery still supports the $805–830 million… VECO Veeco Instruments Inc. LOW Merger-arb tracking stock for Axcelis: fixed 0.3575 ACLS/VECO, both votes cleared 2026-02-06, only China SAMR remains before the 2026-09-30 outside date. ACLS's slide to ~$134 de-pegged VECO to a premium over the exchange ratio (~$48) —… VEEV Veeva Systems Inc. fresh LOW Veeva Systems’ recovery rests on Vault CRM adoption overcoming Salesforce competition, supported by 16% subscription growth reported on 2026-08-26. A daily close above the September 18 reference high of $306.22 would complete the recovery… VERI Veritone, Inc. fresh LOW Veritone’s rebound prices a negotiated resolution of its $45.6 million November debt maturity. The case plays out if repayment, refinancing or extension completes before 2026-11-15 and before a weekly close below $0.50; September’s… VERU Veru Inc. fresh LOW The Novo squeeze is fully round-tripped and the funding answer arrived on 2026-07-02: a $21.8M at-the-market program via Oppenheimer/Canaccord. At $2.42 (07-15) that is ~9M shares against ~16M outstanding — the company will now sell stock… VIAV Viavi Solutions Inc. LOW Networking-optical test theme still accelerating and the laggard test-and-measurement sleeve is finally re-rating: Susquehanna lifted its target to $66 (2026-07-01) and the small-cap-over-hyperscaler rotation flagged 2026-06-29 favors… VICR Vicor Corporation LOW Operating numbers still inflecting (Q2 guide ~$142M, book-to-bill >2.0, backlog $300.6M) but the chart has broken: $237.62 on 2026-07-17 is ~38% off the $382.65 July high, with $271 and $300 both lost and relentless CEO 10b5-1 supply. The… VIOT Viomi Technology Co., Ltd fresh LOW Viomi Technology’s recovery now depends on appliance sales and profit after Nasdaq compliance was restored on 2026-09-18. The case requires second-half revenue above RMB740.0 million and positive net income before a weekly close below… VIR Vir Biotechnology, Inc. fresh LOW Q2 (2026-08-05) printed $238.9M revenue and $0.47 diluted EPS on Astellas upfront recognition — an accounting swing, and the tape read it as one: $9.24 on 2026-08-14, still under the $10.36 Astellas equity strike, with Morgan Stanley and… VKTX Viking Therapeutics, Inc. LOW Viking Therapeutics' maintenance-dosing story needs September data showing retained weight loss with less frequent treatment and a weekly close above $34. The case fails on a weekly close below $30 or a missed September 30 readout window. VMI Valmont Industries, Inc. LOW Valmont Industries’ utility-growth story supports a recovery case that requires a weekly close above $520 with its July earnings guidance maintained or raised. A weekly close below $470 first invalidates the case; the September 11, 2026… VOR Vor Biopharma Inc. LOW Vor Biopharma’s telitacicept pivot depends on positive global Phase 3 results within its first-half 2027 guidance window. The recovery thesis fails if a weekly close below $20 occurs first, while a failed endpoint or delayed results… VOYG Voyager Technologies, Inc. LOW Voyager Technologies’ order-book re-rating needs price recovery and September NASA procurement progress. The case requires a weekly close above the August $38.40 reference before a weekly close below $32, unchanged $275–305 million 2026… VPG Vishay Precision Group, Inc. fresh LOW The AI-precision re-rate broke at the print: Q2 (2026-08-05) missed on revenue ($83.936M vs $84.646M) and adjusted EPS ($0.04 vs $0.19), Q3 guide midpoint sits below consensus, and the stock gapped -26.95% to $73.78 and has since made… VSH Vishay Intertechnology, Inc. LOW Cycle-turn re-rate has fully round-tripped: down ~46% from $69.47 to the high-$30s, now under the $50 June placement and below every covering analyst's target. Q1's 1.34 book-to-bill and $1.6B backlog were real but sit at ~35x forward into… VSTS Vestis Corporation fresh LOW Vestis Corporation's turnaround depends on cost reductions delivering fiscal 2026 earnings and cash-flow guidance. The full-year report tests the $310–315 million adjusted EBITDA and $160–170 million free-cash-flow ranges issued on… VSXY Victorias Secret & Co. LOW Turnaround re-accelerated with no new number: the July mid-$70s range broke, a $99.97 52-week high printed, then 11% came back into the 2026-09-03 Q2 report. Consensus target $91.40 sits ~3% over the $89.02 close on 2026-08-14, so the… WHD Cactus, Inc. fresh LOW International wellhead order narrative from the 2026-07-29 Q2 beat is intact, but the re-rating leg is largely spent: Citigroup cut to Neutral on 2026-08-20 while raising its target to $75, and the shares closed $69.43 on 2026-08-21, 5.8%… WING Wingstop Inc. LOW Two analyst target cuts in ten days (Wells Fargo to $170, DA Davidson to $200) into the 2026-07-29 Q2 print signal de-risking ahead of the H2 comp-turn binary; a ~50% relief bounce off the $116.35 low is unproven, and the print — not… WLFC Willis Lease Finance Corporation LOW Engine-leasing supercycle still printing records (Q1 rev +23%, EPS $4.03 vs $3.02 est), but the theme is maturing and the stock has faded ~18% off its 2026-07-06 ATH into the now-completed 3-for-1 split. The event stack has collapsed to… WRLD World Acceptance Corporation LOW World Acceptance Corporation’s credit-recovery and repurchase thesis needs Q2 revenue above $139.2 million with delinquency no higher than June’s readings. Those results would confirm the operating case if they arrive before a weekly close… WSC WillScot Holdings Corporation LOW Cyclical modular-space leasing recovery with a small data-center kicker and an activist/M&A floor, but range-bound and digesting: shares drifted to ~$26 under the $31.88 high after the 2026-06-27 Russell growth-index removal. The confirmed… WSM Williams-Sonoma, Inc. LOW Williams-Sonoma's August 26 growth-guidance increase supports a recovery toward Evercore ISI's September 9 target of $240. A weekly close above $240 would demonstrate that recovery; a weekly close below $225 would invalidate it. XENE Xenon Pharmaceuticals Inc. LOW Xenon Pharmaceuticals' recovery thesis requires an on-time azetukalner application and a weekly reclaim of the failed $62 shelf. Management guided submission to Q3 2026 on 2026-08-06; a weekly close below $55 or a disclosed filing delay… XHG XChange TEC.INC LOW XChange TEC's AI-insurance acquisition story needs a definitive First Cycle agreement and price recovery to validate it. The case requires a daily close above the $4.62 high reported as of 2026-09-11 before a daily close below that date's… XOS Xos, Inc. fresh LOW First-ever U.S. Air Force award (prototype OTA for the Xos Hub mobile BESS, announced 2026-08-17, terms not disclosed) took the stock ~100% on 2026-08-18 and put a defense-pivot narrative on a going-concern EV maker that just missed Q2… XRAY DENTSPLY SIRONA Inc. LOW Dentsply Sirona's turnaround re-rating failed its published $11 weekly-close test with the $10.46 close on 2026-09-11. A renewed recovery case requires a weekly close above $11, stabilising sales and maintained annual guidance. XRX Xerox Holdings Corporation LOW Distressed-deleveraging special situation that round-tripped its June activist pop into a binary 2026-07-30 Q2 print. At ~$2.60 it sits below the $2.75 Hold consensus and inside the $2.25–$2.50 target band; anchor buyer STARTEEPO (8.8M sh,… XTLB XTL Biopharmaceuticals Ltd. LOW XTL Biopharmaceuticals' psychedelic recovery case requires a disclosed Psyga trial start or binding ibogaine partnership and a weekly close above the June 30, 2026 financing reference of $2.70. A weekly close below $2.20 invalidates it;… YAAS Youxin Technology Ltd LOW Youxin Technology’s residual recovery case requires a weekly reclaim of $2.00 and a definitive RiverBit agreement before a weekly close below $1.00. The previous $2.00 floor thesis failed at the 2026-09-11 close of $1.39. YEXT Yext, Inc. fresh LOW Yext’s margin-and-share-count recovery needs AI products to restart recurring-revenue growth. The case requires next-quarter ARR above $440.8 million before a daily close below $5.90; Envision on 2026-09-30 tests commercial evidence but… YSS York Space Systems Inc. LOW York Space Systems’ procurement-delay recovery case failed when its 2026-09-11 weekly close breached $8.86. Funded orders, backlog growth and recovery of that shelf are required to establish a new case. ZBRA Zebra Technologies Corporation fresh LOW Zebra Technologies’ automation re-rating needs Q3 earnings confirmation after the September 18 close weakened to $346.63. The recovery case resolves with a weekly close above the market’s $383.06 high before a weekly close below $330; Q3… ZENA ZenaTech, Inc. LOW ZenaTech's recovery case requires a priced commercial drone-service contract and a weekly close above the market's August 28 close of $1.71. A weekly close below $1.52 invalidates that case; September's development announcements have not… ZURA Zura Bio Limited LOW Zura Bio’s pipeline-expansion story depends on positive Q4 2026 TibuSHIELD data before a weekly close below $4.90 breaks the setup. The September 11 close of $5.21 and RSI of 39.2 weaken the price evidence; clinical confirmation requires a… ZVRA Zevra Therapeutics, Inc. LOW The June patent re-rating fully reversed: EMA's CHMP issued a negative opinion on arimoclomol's EU application 2026-07-24 (efficacy not proven), and ZVRA gapped ~24% to the high-$9s, cutting through the $11.50 base. EU expansion is now…